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RESUMO 
 
Na presente Tese é descrita a determinação da estrutura tridimensional de duas enzimas dependentes 
de molibdénio, assim como a sua interpretação funcional. No Capítulo 1 é dada uma introdução geral 
acerca da utilização do molibdénio pelos sistemas biológicos, em particular a sua incorporação no 
centro activo de diversas enzimas. No mesmo capítulo, é também apresentada uma visão geral sobre 
a técnica de cristalografia de raios-X de proteínas, assim como alguns princípios básicos da mesma. 
 
As aldeído oxidases são proteínas homodiméricas pertencentes à família da xantina oxidase (XO) de 
enzimas de molibdénio. A estrutura tridimensional da proteína aldeído oxidase homóloga1 (mAOH1) 
de rato encontra-se descrita no Capítulo 2, constituindo a primeira estrutura existente para uma 
aldeído oxidase. A proteína foi simultaneamente extraída de fígado de rato e expressa num sistema 
bacteriano (E.coli). A proteína recombinante permitiu determinar condições favoráveis de 
cristalização. Estas condições foram utilizadas na proteína nativa e levaram à obtenção de bons 
cristais, que possibilitaram a determinação da estrutura a uma resolução de 2.9Å. A estrutura foi 
resolvida por substituição molecular, usando como modelo a xantina oxidase de leite bovino, 
pertencente à mesma família que a mAOH1. No geral as duas proteínas são muito semelhantes, mas 
no entanto, as reações que catalisam são bastante diferentes. A análise da estrutura da mAOH1 e a 
comparação com a estrutura da XO permitiram chegar a importantes correlações entre a estrutura e a 
função, que explicam algumas das diferentes especificidades das duas enzimas. Estes estudos 
contribuem ainda para melhor compreender o papel das aldeído oxidases na saúde humana. Esta 
enzima tem sido objecto de estudo de diversas empresas farmacêuticas, na medida em que está 
envolvida em processos de detoxificação de várias drogas e xenobióticos, assumindo particular 
importância em estudos de “drug design”. 
 
A nitrato reductase periplasmática da bactéria Cupriavidus necator (Cn NapAB) é uma proteína 
heterodimérica, pertencente à família das proteínas de molibdénio DMSO reductase. A estrutura 
tridimensional da Cn NapAB foi obtida a 1.5Å de resolução, a partir de cristais obtidos num robot de 
cristalização. Estudos estruturais, funcionais e espectroscópicos da Cn NapAB encontram-se 
descritos no Capítulo 3. A elevada resolução do modelo permitiu identificar a verdadeira natureza de 
todos os ligandos do molibdénio. Comprovou-se que o 6º elemento de ligação ao metal é um átomo 
de enxofre, e não oxigénio como estava estabelecido desde a elucidação da primeira estrutura de uma 
nitrato reductase (NapA de Desulfovibrio desulfuricans). Pensa-se que esta seja uma característica 
comum a todas as nitrato reductases, o que conduziu a diversas revisões do mecanismo reacional. 
 iv 
 
Para melhor caracterizar a proteína, foram ainda efectuados estudos espectroscópicos e 
electroquímicos, que demonstraram algumas características inesperadas, tal como o potencial redox 
dos dois hemos do tipo-c presentes na enzima. 
 
Uma forma parcialmente reduzida da enzima NapAB de C.necator foi também obtida, e encontra-se 
descrita nos Capítulos 3 e 4. Esta forma foi obtida através da utilização de compostos recentemente 
descritos, e denominados Líquidos Iónicos (IL). Diversos estudos cristalográficos realizados 
utilizando IL como agentes de cristalização, têm-se revelado uma alternativa muito atraente para 
optimização de cristais de proteínas. No caso específico da proteína NapAB de C.necator, estes 
compostos revelaram-se fundamentais para reproduzir em maior escala os micro cristais inicialmente 
obtidos pelo robot de cristalização, e também para a obtenção de cristais da enzima parcialmente 
reduzida, que apresentou características inesperadas no centro activo. 
 
Algumas conclusões gerais do presente trabalho, bem como perspectivas futuras encontram-se 
descritas no Capítulo 5.  
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ABSTRACT 
 
 
This Thesis reports the determination of the crystal structure of two molybdenum-dependent 
enzymes, as well as its functional interpretation. In Chapter 1 is given a general introduction on the 
use of molybdenum in biological systems, particularly its incorporation into the active site of several 
enzymes. In the same chapter is also included an overview on X-ray protein crystallography, briefly 
describing its main basic principles. 
 
Aldehyde oxidases are homodimeric proteins belonging to the xanthine oxidase (XO) family of 
molybdenum containing enzymes. The three-dimensional structure of mouse aldehyde oxidase 
homologue1 (mAOH1) is here reported and described (Chapter 2). This constitutes the first crystal 
structure ever obtained for an aldehyde oxidase. The mAOH1 protein was extracted from rat liver, 
and heterologously expressed in E.coli. The recombinant protein allowed determining suitable 
crystallization conditions, which were reproduced using the native enzyme from mouse liver. 
Suitable crystals were obtained, allowing to solve the protein structure at 2.9Å resolution, using 
bovine milk xanthine oxidase as a search model. Both proteins belong to the XO family of Mo 
proteins and are very similar, although catalyzing different reactions. The structure of mAOH1 and 
its comparison with the XO structure allowed drawing important structure and function correlations, 
and to explain the different enzyme specificities. These studies have also contributed to better 
understand the role of aldehyde oxidase in human health. The enzyme has received considerable 
attention from several pharmaceutical companies, as it is involved in the detoxification of several 
drugs and xenobiotics, assuming particular relevance in human health and drug design studies. 
 
Periplasmic nitrate reductase from the Cupriavidus necator bacterium (Cn NapAB) is a 
heterodimeric protein, and belongs to the DMSO reductase family of molybdenum containing 
enzymes. The three-dimensional structure of the C.necator NapAB was solved at 1.5Å resolution 
using crystals obtained from a crystallization robot. Structural, spectroscopic and functional studies 
of this protein are reported in Chapter 3. The high resolution of the model, allowed identifying the 
true nature of all Mo ligands. In the first reported nitrate reductase crystal structure (NapA from 
Desulfovibrio desulfuricans), the 6th Mo ligand had been identified as an oxygen, but in Cn NapAB, 
a sulfur atom could be unambiguously assigned to this position. It is believed that this is a general 
feature of all nitrate reductases, which has led to the necessary revisions on the reaction mechanism 
for this family of enzymes. To further characterize C.necator NapAB, spectroscopic and 
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electrochemical studies have also been performed, and have shown unexpected features, particularly 
regarding the potential of the two c-type hemes. 
 
A partially reduced form of C.necator NapAB was also obtained, and is described in Chapters 3 and 
4. This form was obtained using some recently described compounds named Ionic Liquids (IL). 
Crystallographic studies performed using Ionic Liquids as crystallization agents, have proved to be 
an attractive alternative for optimizing protein crystals. In the specific case of C.necator NapAB, 
these compounds were fundamental to scale up the initially nano-crystals obtained from the 
crystallization robot, and also in obtaining crystals of the partially reduced enzyme that provided 
unexpected structural features on the protein active site. 
 
Some general conclusions from this work are summarized, and some future perspectives are outlined 
in Chapter 5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 vii 
 
Abbreviations 
  
AO aldehyde oxidase 
AOH1 aldehyde oxidase homologue1 
AOH2 aldehyde oxidase homologue2 
AOH3 aldehyde oxidase homologue3 
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1.1 MOLYBDENUM ENZYMES 
1.1.1 Why Molybdenum? 
Molybdenum is part of life, and part of our lives, and it has long been known that this element is an 
essential nutrient for plants, animals and microorganisms. Molybdenum is the only second row-
transition metal in the periodic table, that is required by the majority of living organisms, and the few 
species that do not require molybdenum use tungsten, which lies immediately below Mo in the 6th 
group (and has similar characteristics).  Molybdenum can be considered a trace element, meaning 
that small amounts are necessary, but higher ones can be toxic or even lethal. Both molybdenum and 
tungsten possess an extraordinary chemical versatility that is useful for biological systems: in the 
case of Mo, its oxidation state varies from +2 to +6, and it can be coordinated to 4 or up to 8 ligands. 
Due to molybdate anion (MoO42-) solubility in water, molybdenum is easily available to the 
biological systems. In soils, for instance, the MoO42- anion is the only form of molybdenum available 
to plants and bacteria [1, 2]. 
 
Although a minor constituent of the earth’s crust, molybdenum is the most abundant transition metal 
in seawater, which resembles the primitive initial soup from where life emanated. So it is not 
surprising that it has been incorporated in a diverse range of biological systems such as nitrogenases 
and molybdopterin-dependent enzymes. Molybdenum itself is inactive, and in order to gain 
biological activity, it has to be complexed by a pterin compound forming the molybdenum cofactor 
(pyranopterin - MoCo), which is part of the catalytic center of nearly all molybdenum containing 
enzymes. This can be considered the most important use of molybdenum in living organisms [1, 2]. 
 
1.1.2 Molybdenum Cofactor 
The majority of MoCo dependent enzymes catalyze redox reactions. These proteins take advantage 
of the chemical versatility of the metal, which is controlled by the cofactor itself and the enzyme 
environment. Two very different systems have developed in nature to control this redox state and 
catalytic power of molybdenum, which has the ability to function as a catalyst in oxygen transfer 
reactions. With the exception of the multinuclear MoFe7 cluster present in bacterial nitrogenases, all 
other molybdenum dependent enzymes use the metal in a mononuclear form, with an organic 
tricyclic pyranopterin cofactor coordinated to it. Only in the case of carbon monoxide dehydrogenase 
(CODH), Mo has been found in a dinuclear Mo-S-Cu form [3]. The cofactor was originally thought 
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to be present only in Mo enzymes, so it was initially named MoCo. It was later discovered that this 
cofactor is also present in tungsten enzymes, and its designation was changed to pyranopterin to 
avoid confusion. The cofactor coordinates to the metal via its dithiolene function, and although 
representing an integral component of the active center of these enzymes, it does not seem to 
participate directly in catalysis. The pterin can be present in either its dinucleotide or monophosphate 
form. While in eukaryotes the pyranopterin is in the simplest monophosphate form (MPT), in 
prokaryotes it can also be conjugated to nucleosides, usually cytidine (MCD) or guanosine (MGD) 
(Figure I. 1). The cofactor is responsible for the correct positioning of molybdenum in the active 
center, for the control of its redox behavior, and also participates in the electron transfer that occurs 
to and from the metal. Molybdenum containing enzymes are found in all aerobic organisms, whereas 
tungsten enzymes occur essentially in obligate anaerobes (typically thermophilic) [1, 4-6]. 
 
Figure I. 1 - The mononuclear Mo and W enzymes pyranopterin cofactor (MoCo) structure:  in blue, the monophosphate 
form (MPT); in yellow and green, respectively, guanosine (MGD) and cytidine (MCD) dinucleotide form. 
 
The mononuclear molybdenum enzymes are widely distributed in nature, dispersed in a variety of 
organisms from all different kingdoms. Although catalyzing a wide diversity of reactions in the 
metabolism of nitrogen, sulfur and carbonyl compounds, the MoCo cofactor is synthesized by a 
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conserved pathway. Using several biochemical, genetic, and structural approaches, MoCo 
biosynthesis in E.coli has been extensively studied. These studies have identified at least 17 different 
genes involved in the biosynthesis of this complex cofactor. The biosynthetic pathway can be briefly 
divided in four main steps, according to its intermediates: (i) formation of cyclic pyranopterin 
monophosphate (cPMP); (ii) conversion of cPMP to metal-binding pterin (MPT); (iii) insertion of 
molybdenum to form MoCo; and (iii) additional modification of MoCo by the attachment of 
different nucleotides to form the cytosine or the guanosine cofactors (MCD and MGD, respectively) 
(Figure I. 2). The first three steps are similar for all molybdenum containing proteins for all 
microorganisms, but the final modification step varies between different proteins and organisms, 
occurring only in prokaryotes. Mutational block of the cofactor biosynthesis, results in loss of 
essential metabolic functions [4, 6, 7]. 
 
Figure I. 2 – General scheme of the three main steps involved in the biosynthetic pathway of the pyranopterin-based Mo 
cofactors. (Adapted from [6]) 
 6 
  
1.1.3 Molybdenum Containing Enzymes 
More than 50 different MoCo containing enzymes have been described to date, which have been 
classified on the basis of the Mo active site coordination characteristics [5]. The majority of Mo 
dependent proteins catalyze oxo-transfer reactions, coupled to electron transport between substrate 
and other cofactors, namely iron-sulfur centers, hemes or flavins. In the catalytic center, 
molybdenum is coordinated to the cis-dithiolene group of one or two pyranopterins. Coordination is 
completed by the side chain of a cysteine, seleno-cysteine, serine or aspartate residue, and/or by 
coordination of a oxygen or sulfur atom in the oxo or sulfide group forms. These coordinating 
elements have such a large diversity that, based on X-ray structural data, primary sequence 
alignments and biochemical characterization, pyranopterin containing enzymes have been divided in 
to three large families, summarized in Table I. 1: the xanthine oxidase (XO) family, with one MCD 
or MPT; the sulfite oxidase (SO) (and assimilatory nitrate reductase) family, with one MPT; and the 
DMSO reductase (DMSOR) family, containing two MGD cofactors [5, 6, 8]. 
 
All eukaryotic molybdenum enzymes belong exclusively to either the sulfite oxidase or the xanthine 
oxidase family. They differ in the nature of the third Mo-S ligand, which is either provided by a 
terminal sulfido ligand (XO) or an enzyme-derived cysteine (SO).  Members of the DMSOR family 
are very diverse in terms of reaction, function and structure, and the majority of them work under 
anaerobic conditions, whereby their respective cofactors serve as terminal electron acceptors in 
respiratory metabolism. Some tungsten containing enzymes, such as Desulfovibrio gigas formate 
dehydrogenase (Fdh), belong to the DMSO reductase family, and have high homology with the 
corresponding molybdenum enzymes. A new protein catalyzing the oxidative hydroxylation of 
amine substrates has been recently described, in both humans and plants. Mitochondrial amidoxime 
reducing component (mARC), appears to contain a distinct molybdenum coordination sphere, and 
could represent a new family of eukaryotic molybdenum enzymes [5, 6, 9, 10].  
 
The study of molybdenum enzymes has become increasingly facilitated in recent years, mainly due 
to the possibility of heterologous protein expression in prokaryotic systems. The expression of 
molybdoenzymes is however an extremely complex process, controlled by the transportation of Mo 
into the cell, by the cofactor biosynthesis and apo-protein expression transcriptional regulation [8]. In 
recent decades, crystal structures for several members of the XO, SO and DMSO reductase families 
have provided considerable insight into how active site architecture is implicated in substrate 
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specificity, and enabled reaction mechanism determination. Crystallographic studies of 
molybdoenzymes have revealed that MoCo is deeply buried within the enzyme, and usually in close 
proximity to the iron/sulfur centers. A more detailed characterization of representative enzymes of 
each family is given below. 
 
 
Table I. 1 - Representative pyranopterin dependent enzymes and respective families. 
 
1.1.4 Xanthine Oxidase Family 
Enzymes of the xanthine oxidase (XO) family are the best characterized mononuclear molybdenum 
containing enzymes, and in general catalyze the oxidative hydroxylation of a diverse range of 
aldehyde and aromatic heterocycles. The chemical reaction involves the cleavage of a C-H bond, and 
the formation of a new C-O bond: 
RH + H2O  !  ROH  +  2H+  +  2e- 
This reaction occurs after substrate interaction with the Mo center, which is later reduced from Mo 
(VI) to Mo (IV). The two resulting reducing equivalents are transferred to a protein external 
acceptor: NAD+ in the case of xanthine dehydrogenase (XDH), or O2 in xanthine oxidase, along an 
electron transfer pathway. This process occurs through the protein cofactors, which mediates the 
electronic exchange between substrate and the electron acceptor. Molybdenum enzymes of the 
xanthine oxidase family catalyze hydroxylation of carbon centers, and use water as oxygen atom 
source, rather than O2 that is later incorporated into the product [11, 12].  
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Members of this family are broadly distributed in eukaryotes, prokaryotes and archaea, and comprise 
xanthine oxidoreductases (XOR), aldehyde oxidases (AO) and carbon monoxide dehydrogenases 
(CODH).  Xanthine oxidoreductases have been isolated from a wide range of organisms, and are the 
most well studied enzymes of the XO family of molybdenum proteins, since its crystal structure was 
solved in 2000, by Nishino and co-workers [13]. These mammalian proteins constitute the key 
enzymes in the catabolism of purines, oxidizing hypoxanthine to xanthine, and xanthine into the 
terminal catabolite uric acid. They are synthesized in the dehydrogenase form (XDH) and exist 
mostly as such in the cell. By oxidation of sulfhydryl residues or by proteolysis, XDH can be 
converted into oxidase form (XO), which fails to react with NAD+ and exclusively uses dioxygen as 
electron acceptor. This results in the formation of reactive oxygen species, namely superoxide anion 
and hydrogen peroxide [5, 13].   
 
Eukaryotic xanthine oxidoreductases usually exist as homodimers, and each monomer can be divided 
into three distinct domains, according to cofactor localization. The N-terminal domain harbors a pair 
of spectroscopic distinct [2Fe-2S] centers, followed by a FAD containing domain, and a C-terminal 
domain containing the molybdenum center and cofactor. In the case of prokaryotic enzymes a 
different and more complex structure can be found. XDH from Rhodobacter capsulatus is a dimer of 
dimers, combining a fusion of the FAD and [2Fe-2S] domains into one subunit (XdhA), and the 
molybdenum-binding portion into another (XdhB). The catalytic Mo active site possesses a distorted 
square pyramidal coordination geometry. The apical position is occupied by a Mo=O group, and the 
four equatorial ligands are: two sulfurs from the pyranopterin cofactor, a terminal Mo=S group, and a 
Mo-OH ligand. Generally, electron transfer pathway proceeds from Mo to the nearest iron/sulfur 
center, and from this (usually Fe/SII) to the next iron/sulfur center, until the electrons reach FAD. In 
a different variation, prokaryotic aldehyde oxidoreductase from Desulfovibrio gigas (MOP) does not 
contain the FAD cofactor, and electrons are passed through a complex of several subunits and redox 
centers [11, 12, 14]. 
 
MoCo-dependent enzymes from the XO family that also contain the FAD cofactor have been 
classified in a sub-family named molybdo-flavoenzymes (MFEs) [15]. The most representative 
enzymes are the eukaryotic aldehyde oxidases, and the xanthine oxidoreductases.  
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Unlike xanthine oxidoreductases, which have been studied for more than a century, information on 
the physiological role of aldehyde oxidase in vertebrates, mammals and humans in particular, is still 
vague, in spite of the emerging amount of data on their primary structure. Despite the tremendous 
level of similarity, aldehyde oxidase and xanthine oxidoreductases have different substrate and 
inhibitor specificities, as well as biochemical functions. XOR recognize xanthine and hypoxanthine 
as substrates, but neither of them is a good substrate for the aldehyde oxidase proteins purified so far 
(including the homologues, explained in detail in Chapter 2). AO has relaxed substrate specificity, 
meaning that the protein can accommodate various types of compounds, generally characterized by 
aldehyde functionality (an aromatic or heterocyclic structure). It is also interesting to point out that 
allopurinol and oxipurinol, strong inhibitors of XOR, can inhibit AO to a lesser extent [13, 16, 17]. 
 
There is an urgent need to determine the “missing” three-dimensional structure of an aldehyde 
oxidase. This will allow for the identification of the structural determinants that form the basis of the 
different substrate specificities between AO and XOR. New structural and spectroscopic studies can 
also help to elucidate the exact nature of the molecular processes that occurs during catalysis. This 
would also improve our understanding in the evolution of these proteins [11, 12, 16, 18]. 
 
1.1.5 Sulfite Oxidase Family 
The sulfite oxidase family comprises plant assimilatory nitrate reductases and sulfite oxidizing 
enzymes. The sulfite oxidizing enzymes can be separated in two groups according to their ability to 
transfer electrons to molecular oxygen: the sulfite oxidase (SO) found in animals and plants; and the 
sulfite dehydrogenases (SDH) encountered in bacteria. In animals, SO enzymes catalyze the 
oxidation of sulfite to sulfate, using ferricytochrome c as the physiological electron acceptor: 
SO32-  +  H2O  +  2 (cyt c)ox  !  SO42-  +  2 (cyt c)red  +  2H+ 
This constitutes the final step in the oxidative degradation of sulfur containing amino acid residues 
cysteine and methionine. SO also plays an important role in detoxifying the excess of sulfite and 
sulfur dioxide, exogenously supplied [5, 19]. 
 
In the oxidized (Mo VI) state of the enzyme, the molybdenum atom is in a distorted square 
pyramidal coordination geometry connected by five ligands: two from the dithiolene group of 
molybdopterin (MPT), the side chain of a strictly conserved cysteine, and two non-peptide oxygen 
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atoms (Table I. 1). Animal sulfite oxidase is a homodimer, located in the mitochondrial 
intermembrane space. Each subunit contains three distinct domains: a Mo cofactor domain, a 
dimerization domain and a smaller heme containing domain. The X-ray structure of human SO is not 
yet available, but the structure of the highly homologous chicken liver was solved in 1997 by Kisker 
and co-workers [20]. Also the crystal structures from plant Arabidopsis thaliana sulfite oxidase, 
which is the smallest eukaryotic Mo enzyme (lacking the heme domain), and the soil bacteria 
Starkeya novella sulfite dehydrogenase (SDH) were determined some years later [21, 22]. Unlike 
animal SO, the plant enzyme is localized in peroxisomes, and does not react with cyt c, but uses 
oxygen instead as the terminal electron acceptor. It is also important to note that, all the other 
families of molybdenum containing enzymes contain [Fe-S] clusters, or interact with iron/sulfur 
subunits, while members of the SO family do not [8, 19]. 
 
In humans, sulfite oxidase deficiency is an inherited sulfur metabolic disorder, resulting in deep birth 
defects, severe neonatal neurological problems and early death. Schwarz and co-workers may be 
close to a treatment (unpublished results), but to date no effective therapies are known. This 
deficiency can be caused by mutations in the SO gene, or due to defects in the MoCo biosynthetic 
pathway, as mentioned in section 1.1.2. Mutations in the genes can be divided into three groups: 
mutations causing conformational changes in the protein active site; mutations affecting dimerization 
contacts; and mutation of residues coordinating MoCo [19, 23]. 
 
1.1.6 DMSO Reductase Family 
The dimethyl sulfoxide (DMSO) reductase family of molybdenum enzymes is the largest and 
displays a greater diversity. With the exception of formate dehydrogenases (Fdh), the members of 
this family catalyze in general the transfer of an oxygen atom, to or from the substrate. The first 
crystal structure reported for this family was the DMSO reductase from Rhodobacter sphaeroides, by 
Schindelin and co-workers [24]. Nevertheless, our knowledge about this family was greatly 
increased with further studies on nitrate reductases and formate dehydrogenases. Interestingly, all 
crystal structures determined to date from the DMSO reductase family of proteins possess high 
degree of similarity and overall fold, and considerable variations in metal coordination and active 
site amino acid residues. In the active site, the metal is coordinated by two pterin cofactors in the 
dinucleotide form (MGD) and different types of ligands. These differences account for the high 
diversity of functions performed by the enzymes of this family [5, 25]. 
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Nitrate Reductases 
Nitrogen is essential for biomolecules, such as proteins and nucleic acids. The nitrogen cycle 
involves a number of redox reactions in which prokaryotes have an important role, since only they 
possess the enzymatic machinery necessary to carry out the process. The dissimilatory reactions 
involve conversion of nitrate into dinitrogen (respiration), or into ammonia (respiration 
/ammonification). The assimilatory ones (which also involve conversion of nitrate to ammonia), start 
with the reduction of nitrate in the cytoplasm. All the reductive steps of the nitrogen cycle are started 
by nitrate reductases (NR), with release of one water molecule: 
NO3-  +  2H+  +  2e-  !  NO2-  +  H2O 
With the exception of eukaryotic assimilatory nitrate reductase from the SO family, all other nitrate 
reductases belong to the DMSO reductase family. There are three kinds of nitrate reductase that can 
be used to initiate the respiratory denitrification, or ammonification processes in prokaryotes. All of 
them bind a Mo-bis-molybdopterin guanine dinucleotide cofactor and at least one [4Fe-4S] center. 
Nitrate reductases are divided according to their cellular localization: Nar is a complex protein 
anchored to the membrane, Nap is located in the periplasmic compartment and Nas can be found in 
the cytoplasm [26, 27] (Figure I. 3). 
  
Respiratory nitrate reductases (Nar) in bacteria have been extensively studied. All the Nar proteins 
isolated to date are composed of three different subunits (NarGHI): NarG which contains the MoCo 
active site plus a [4Fe-4S] center; NarH which has three additional [4Fe-4S] centers, and a [3Fe-4S] 
center; and NarI, which is an integral membrane protein with two b type hemes. NarG and NarH are 
in the cytoplasm, anchored to the membrane by NarI. Crystal structures for NarGHI, and NarGH 
were reported some years ago by Bertero and Jormakka, and co-workers respectively [28, 29]. These 
structures revealed interesting aspects, such as the presence of an aspartate side chain as a 
molybdenum ligand. Nar receives electrons from quinol, usually ubiquinol in denitrifiers, and is 
therefore linked to respiratory electron transfer [5, 27]. The periplasmic dissimilatory nitrate 
reductases (Nap) are also linked to quinol oxidation, but do not transduce the free energy from the 
quinol/nitrate couple into H+ motive force. In Nap, electrons from quinol are usually transferred 
through one or two cytochrome containing proteins (NapC or NapB) to the catalytic subunit NapA, 
which contains the MoCo cofactor and a [4Fe-4S] center [27]. The first crystal structure of a 
dissimilatory nitrate reductase was solved in 1999, by Dias and co-workers [30]. This nitrate 
reductase isolated from Desulfovibrio desulfuricans (Dd) is a monomeric NapA protein, while the 
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majority of Nap enzymes purified from other organisms, such as Rhodobacter sphaeroides (Rs), 
reveals the presence of a small NapB subunit, containing two c-type hemes [31]. In the oxidized 
form, molybdenum is coordinated by four sulfurs from the dithiolene moiety (bis-MGD), a cysteinyl 
ligand from the polypeptide chain, and a recently established sulfur ligand, in a distorted hexa-
coordinated MoVI geometry. The enzymatic mechanism of this group of proteins, have been recently 
revised and discussed, based on new structural evidences found in the Dd NapA, and corroborated 
with the recent crystal structure of Cupriavidus necator NapAB [32, 33]. The high resolution (1.5Å) 
crystal structure of C.necator NapAB is discussed in detail in Chapter 3 of this Thesis. 
 
 
Figure I. 3 - Nitrate reductases localization: NarGHI is membrane anchored, NapAB in the periplasm, and NasA in the 
cytoplasm. (Adapted from [27, 34]) 
 
The assimilatory nitrate reductases (Nas) from different organisms have in common the presence of 
the Mo-bis-MGD cofactor, but differ largely in the number and type of electron transfer centers. No 
crystal structure has been reported for this sub-group of proteins, but monomeric Nas from 
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cyanobateria are closely related to Dd NapA, indicating that Nas proteins are more related with Nap, 
than with Nar [35]. 
 
Formate Dehydrogenases 
The few examples of enzymes capable of incorporating molybdenum or tungsten in their catalytic 
active site belong to the DMSO reductase family. Formate dehydrogenase (Fdh) is one of them, and 
it catalyzes the oxidation of formate to carbon dioxide: 
HCOO-  !  CO2  +  H+  +  2e-   
The two Fdh proteins from E.coli (Fdh-H and Fdh-N, from the formate lyase complex and membrane 
bound, respectively) contain molybdenum in the catalytic center, while Fdh from D.gigas has 
tungsten. In spite of some heterogeneity in the protein assembly (E.coli Fdh-H is a monomer, while 
Fdh-N a heterotrimer and Dg Fdh is a heterodimer), the three known crystal structures of formate 
dehydrogenases exhibit very similar active site geometries. The Mo/W metal adopts a distorted 
trigonal prismatic geometry and is coordinated to four dithiolene sulfur atoms (from the two MGD 
cofactors) by a selenium atom from a conserved SeCys residue and by a sixth oxygen or sulfur 
ligand. Also the overall three dimensional structure and cofactor arrangement is very similar in the 
three enzymes [5, 25]. 
 
Given all the above and considering that the first three-dimensional crystal structure of a Mo enzyme 
was determined only 16 years ago (MOP protein, in 1995 by Romão and co-workers), the 
achievements made for this family of enzymes in such a small period of time are remarkable. This 
was possible mainly due to the information obtained from X-ray protein crystallography, 
complemented by spectroscopic and functional studies. The importance of X-ray protein 
crystallography is explained next. 
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1.2 BIOMOLECULAR CRYSTALLOGRAPHY 
X-ray crystallography of important biological molecules started with Dorothy Hodgkin (1910-1994), 
who solved the structure of small molecules such as cholesterol, vitamin B12 and penicillin [36]. In 
1950, the first protein crystal structure of sperm whale myoglobin was solved by Max Perutz (1914-
2002) and Sir John Kendrew (1917-1997). D. Hodgkin was also able to solve the structure of a 
protein (insulin), but only in 1969, after more than thirty years of working on it. These were great 
achievements that were awarded the Nobel Prize in Chemistry, to D. Hodgkin in 1964, and to 
Perutz/Kendrew in 1962. All of this happened no more than 60 years ago, and this year (July 2011), 
there were over 74400 structures deposited in the protein data bank (PDB). Although some of them 
were obtained by other techniques, namely Nuclear Magnetic Resonance (NMR) and Cryoelectron 
Microscopy (cryoEM), the majority (>85%) of the structures were determined by X-ray 
crystallography. How can the great success of this technique be explained? 
 
1.2.1 From X-rays to Crystal Structure 
The determination of molecular structures by crystallography became possible with the discovery of 
X-rays, by Wilhelm Röntgen in the late 19th century. The name X-rays was due to the fact that this 
was an unknown type of radiation at the time, but in Germanic language it is still called Röntgen 
radiation. X-rays are a high-energy electromagnetic radiation and thus part of the electromagnetic 
spectrum, with wavelength between ultraviolet (UV) and gamma (") rays. The major advantages of 
X-rays are its high energy and short wavelength, similar to the inter-atomic bond distances, 
approximately 1Å. X-rays can be obtained by shooting a metal target (usually Cu or Mo, to obtain 
higher or shorter wavelength, respectively) with electrons produced by a heated filament and 
accelerated by an electric field. Due to their wave behavior, X-rays can be diffracted by the 
periodically arrangement of atoms in a crystal. Once obtained, a diffraction pattern from the X-ray 
scattering in the crystal can be used to construct electron density maps. However, additional phase 
information is first needed to overcome the phase problem in crystallography. It often needs 
acquisition of new diffraction data with added information from anomalous scatterers or heavy 
atoms, when estimates of the phases cannot be obtained from homologous structures. Once the phase 
is solved, the preliminary model can be built into the experimental electron density map, which must 
be progressively completed and refined. Validation is also necessary prior to deposition of the 
coordinates in the PDB [37-39]. X-ray crystallography can be viewed as a super microscope: we use 
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the “lens” to focus the diffraction pattern obtained when we pass X-rays through the orderly packed 
molecules in the crystal, and the similarity in magnitude between X-rays and inter-atomic bond 
lengths gives us the possibility to actually see the internal arrangement of atoms in our protein. This 
process is a pipeline, from crystal to structure, which is summarized in Figure I. 4 and will be 
explained below. 
 
Figure I. 4 - The crystal to structure pipeline: most important steps in X-ray protein Crystallography. 
 
1.2.2 Protein Crystallization and Crystal Symmetry 
In order to determine the three-dimensional crystal structure of a macromolecule such as a protein, 
we must start by its expression (in the case of recombinant sources), isolation and purification. The 
diversity of protein purification and characterization techniques existing nowadays, such as 
chromatographic methodologies, has made crucial contributions in making our life easier. All 
crystallographers are nowadays familiar with the protein they are studying, since it’s 
“crystallizability” can be determined a priori by some intrinsic properties. Obtaining crystals from a 
protein is still considered the rate-limiting step in X-ray crystallography. Due to the difficulty in 
predicting the ideal crystallization conditions, many initial crystallization screens with different 
precipitants, concentrations, pHs and temperatures, must be performed. In the most popular manual 
way for growing protein crystals - the vapor diffusion technique - a protein/precipitant mixture is 
allowed to equilibrate over a reservoir, containing larger amounts of the aqueous precipitant solution. 
A siliconized glass slide covers and seals the reservoir, and water is slowly exchanged by controlled 
evaporation. To setup the crystallization process, the protein/precipitant solution can be placed in the 
cover slip itself, or in a support inside the crystallization reservoir - hanging and sitting-drop, 
respectively (Figure I. 5-a). The concentration of protein and precipitant in the drop slowly increases 
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by water transference to the more concentrated solution in the reservoir. When protein solubility 
limit is reached, the system reaches equilibrium and the exchange of water ceases. The final 
concentration of precipitant in the protein solution is supersaturated, and equal to the reservoir. If our 
crystallization conditions are within the supersaturating zone (Figure I. 5-b), nucleation can occur 
and the formation of crystalline nuclei may lead to a protein crystal, which should be an orderly 
three-dimensional array of molecules. Protein crystals have a high solvent content (# 20 - 80%) and 
therefore are very fragile. They must be harvested in mother liquid solution with higher precipitant 
concentration, and transferred to a suitable cryoprotectant solution, usually glycerol, before data 
collection experiments. This procedure prevents crystal dissolution /degradation, as well as radiation 
damage by the intense X-rays, respectively [37, 38, 40]. 
 
Figure I. 5 – (a) Vapor diffusion techniques: Left hanging-drop, right sitting-drop. Hanging-drop is commonly used in 
manual setups, while sitting-drop is preferred for robotic setups; (b) Solubility phase diagram: between the solubility line 
(blue) and the decomposition line (red), lies the metastable region representing the supersaturated protein solution, where 
the formation of crystals will eventually occur. 
 
Nowadays the use of crystallization robots for automated crystallization setup is becoming popular. 
Most of the proteins that are difficult to crystallize are also those that are difficult to produce. The 
most significant advantage of robotic systems is the ability to miniaturize the crystallization drops 
(usually to the nanodrop scale), which allows a considerable increase in the number of conditions 
tested for the smaller amount of protein available [38]. 
 
A crystal is an orderly repetition in the three dimensional space of identical blocks, called unit cells. 
Each unit cell is characterized by its unit cell constants: the lengths of its three edges (a, b and c), and 
the angles between them ($, % and "). The crystal unit cell contains one or more asymmetric units, 
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related by crystallographic symmetry. An asymmetric unit is the smallest unit of volume which 
contains all the structural information. Application of symmetry operations to the asymmetric unit 
generates the unit cell, while lattice translations of the unit cell generate the entire crystal. There are 
4 different types of possible unit cells (P, C, I and F, Table I. 2), which combined with the 7 different 
existing crystal classes, leads to the 14 Bravais lattice. If we imagine a set of constructs dividing 
space in regular units, we can fit the content of our crystal in one of 230 different space groups 
generated by the allowed rotation and translation symmetry operations of the asymmetric unit (all of 
them described in The International Tables for Crystallography, Volume A, http://it.iucr.org/). 
However, as biological molecules are inherently chiral, neither mirror planes nor inversion centers 
are allowed, which reduces the number of possible space groups for proteins to 65 (Table I. 2). 
 
 
Table I. 2 - Crystal systems and allowed space groups for protein molecules. Four types of unit cell: Primitive (P); 
Centered in the side (C), in the body (I), or in the face (F). The spheres in the Bravais Lattice represent the lattice points. 
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Crystals are necessary in an X-ray experiment because an amorphous aggregate of molecules would 
disperse the incoming X-rays, and no diffraction would be produced. The molecules need to be 
arranged regularly forming a crystal, in such a way that the waves diffracted by each molecule can be 
summed, yielding a diffraction pattern. 
 
1.2.3 How to obtain Data from Crystals? 
1.2.3.1 Bragg’s Law and Diffraction 
In 1913, William L. Bragg and his son, William H. Bragg, formulated a physical model to explain 
conditions were diffraction was observed. They considered that in a crystal lattice, regularly spaced 
parallel planes (characterized by h,k,l - the Miller indices) could be drawn through equivalent points. 
If the planes were populated by atoms or molecules, they would reflect X-rays like mirrors. Since X-
rays penetrate the crystals, reflections from successive lattice planes were extinguished by 
interference, unless the reflected rays were in phase with each other. Considering & as the wavelength 
of the X-rays, d as the perpendicular distance between the successive planes, ' as the angle between 
the planes and the incident or reflected X-ray, and n as an integer, then reinforcement of waves 
occurs only when equation in Figure I. 6 is obeyed [41]: 
 
 
Figure I. 6 - Bragg diffraction equation (left) and geometric construction (right): If two beams with identical wavelength 
and phase approach a crystalline solid and are scattered, constructive interference occurs when the length 2dhkl sin' is 
equal to an integer multiple of the wavelength of the radiation (Adapted from [37]).  
 
This is known as the Bragg’s law. If the scattered waves from X-rays are in phase, they interfere 
constructively and Bragg’s Law is obeyed leading to a diffraction pattern. However, if the waves are 
 19 
 
out of phase, they are canceled out by destructive interference, and there is no diffraction. Usually, 
the families of planes that divide the crystal unit cell edges in integer fractions are the ones that allow 
constructive interference. This model also helps to have an idea about data collection geometry, since 
the number of measurable reflections depends on the information present in the unit cell of the 
crystal. Large cells contain more atoms and more information in the diffraction pattern [37].  
 
The periodicity of molecules in the crystal amplifies the diffracted source beam into many distinct 
beams, each of which produces a distinct reflection (currently named spot) on the detector. With 
monochromatic X-rays and a stationary crystal, Bragg’s law would be met for only a few sets of 
planes, but rotation of the crystal makes reflections from different sets of planes to become visible, 
one by one. Each reflection can be treated like a wave, and its phase and intensity contains the 
information necessary to determine the molecular structure of the protein. There is an inverse 
relationship between the space of unit cells in the crystal (crystal lattice), and the spacing of 
reflections in the detector (reciprocal lattice). In the crystal (real space), the position of an atom in 
the unit cell (lattice point) can be specified by a set of spatial Cartesian coordinates (x,y,z) 
considering one of the vertices of the cell as the origin, but in the diffraction pattern (reciprocal 
space), a reflection position is given by the (h,k,l) indices and the central reflection is taken as the 
origin (Figure I. 7) [37, 41]: 
 
Figure I. 7 - Representation of a basic X-ray diffraction experiment: the crystal when exposed to X-rays produces 
individual reflections in the detector. Diffraction images are a transformation (FT) of the crystal real space (real lattice) 
into reciprocal space (reciprocal lattice) and vice-versa. 
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At the end of a diffraction experiment, or even after obtaining just a few diffraction images, we can 
calculate the space group and the unit cell parameters of the crystal. Also, the number of molecules 
present in the asymmetric unit and its volume can be determined. Protein crystals are composed not 
only of the repeating motif of the asymmetric unit, but also of solvent channels containing the 
compounds present in the crystallization solution and in the protein stock solution. Solvent content 
analysis was first calculated by Matthews in the 60s, [42] who plotted the volume of the asymmetric 
unit (V) against the molecular weight of the protein (Z x Mp). Z is the number of asymmetric units 
present in the unit cell, and is determined by the space group. The ratio of these two values is known 
as the Matthews coefficient, and is defined as VM with dimensions Å3Da-1. In general, protein 
structures have a solvent content of 30-70%, and crystals that diffract at higher resolution, usually 
possess lower solvent content [38]: 
VM = V/ (Z x Mp) 
 
We should be aware that when multiple copies of the same molecule are present in the asymmetric 
unit, they are related by local non-crystallography symmetry (NCS).  This should not be confused 
with the crystallographic symmetry operations of the asymmetric unit, which generates the 
crystal.The direct results of a diffraction experiment are now held by the crystallographer: space 
group and crystal unit cell parameters have been determined, solvent content was calculated, and 
intensity data from the individual reflection points can now be indexed, to improve consistency and 
maximize accuracy. However, the real purpose of the crystallographer research remains: the location 
of atoms inside the unit cell is still unknown. 
 
1.2.3.2 Electron Density and the Phase Problem 
To obtain the structure of the individual diffracting motif, or the distribution of electrons in the 
asymmetric part of the crystal, it is necessary to calculate the Fourier transform of the so-called 
structure factors, or F values (F(h,k,l)), for all Miller indices (h,k,l). A structure factor describes one 
diffracted X-ray, which produces one reflection received at the detector. The Fourier transform 
describes the mathematical relationship between an object and its inverse; it maps objects and 
functions from one space or domain into its reciprocal one and vice versa.  Electron density (() in the 
reciprocal space, can be given by a Fourier transform of the sum of periodic functions describing the 
atoms positions (x,y,z) in the real space (crystal) (Figure I. 8): 
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Figure I. 8 - The Phase Problem in Crystallography: to reconstruct the electron density map, the structure factor 
amplitude and the phase angle for each reflection, must be supplied. Fhkl is obtained experimentally but $hkl is not, and 
must be acquired from additional phasing experiments. V is the volume of the unit cell. (Adapted from [38]). 
 
This means that if we know the amplitudes (F) and the phase angle ($) of the diffracted waves, we 
can calculate the electron density map (( (x,y,z)). When the reflections from the diffraction 
experiment are indexed, a long list of intensities (Ihkl) and associated errors ()hkl) are obtained, for 
each single reflection acquired. The intensities are proportional to the square of the amplitudes, and 
so F(h,k,l) can be obtained from *I(h,k,l). However, in the diffraction experiment there is no information 
available regarding the phase angle that reaches the detector, which enables us to calculate the 
electron density map directly from the equation. To overcome this phase problem, several methods 
have been developed in protein crystallography to obtain the missing phases. Some of them require 
additional diffraction information which must be acquired from new experiments. The initial electron 
density map obtained will still need to be improved in an iterative way [38, 39]. 
 
1.2.3.3 Phase Determination and Model Building 
Due to the lack of phase information in the diffraction patterns, direct reconstruction of the electron 
density map via Fourier transforms is not possible from the intensity data alone. Obtaining the 
phases, or solving the structure, is the most challenging part of the process following crystal growth. 
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In protein crystallography there are two major methods to achieve this: molecular replacement and 
multiple isomorphous (heavy atom or anomalous scatterer) replacement.  
 
Molecular Replacement (MR) 
If a similar model of our protein exists and has been already determined, it can be used to calculate 
the initial missing phases. The correct position of the search model in the crystal needs to be found, 
and therefore this method is called molecular replacement (MR), in the sense of repositioning but not 
substituting the search model. Although easily applicable, this method needs to be used carefully. 
Phase bias is introduced due to phase domination above the intensities during electron density 
reconstruction. The initial structure may largely reflect the features of the search model and not the 
features of the real one, therefore it is necessary to use procedures which remove phase bias to obtain 
a model as accurate as possible. The importance of this method is visible in the protein data bank 
statistics since more than 70% of the deposited structures were solved by molecular replacement. 
The work reported in this thesis is not an exception. The two crystal structures described here were 
solved using molecular replacement, with similar proteins as search models. 
 
Multiple Isomorphous Replacement (MIR) 
In the absence of a suitable similar model with known structure, the phases must be determined using 
a separate diffraction experiment. These alternative methods depend on the determination of a 
marker atom substructure, using the intensity differences between isomorphous data sets, which are 
usually very weak. Traditionally, these differences are found between native and derivative crystals, 
containing a heavy atom (e.g. mercury, platinum, or gold), soaked into the crystal without 
significantly altering its unit cell dimensions or positions of the protein atoms. From two or more 
such derivatives it is often possible to obtain enough phases to solve the native data set by multiple 
isomorphous replacement (MIR). The heavy atom substructure provides the initial phase estimates 
required to reconstruct the electron density. Another method now more commonly applied uses 
anomalous dispersion differences instead, whereby multiple data is collected from the same crystal 
containing an anomalous scatterer, but at different wavelengths. One example of this method is 
replacing the amino acid methionine, by selenomethionine through overexpressing the protein in a 
suitable system. The Se atom provides a proper site source for anomalous phasing signal. The choice 
of wavelengths above and below absorption edges is possible nowadays because of the availability of 
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tunable synchrotron radiation, which provides maximum differences in anomalous dispersion effects. 
This method is called MAD; multi wavelength anomalous dispersion method [38]. 
 
The above methods allow obtaining an estimate of the phase information. In almost every case, the 
initial model of the protein structure obtained is further enhanced by various density modification 
techniques, providing substantially improved electron density maps into which the protein structure 
model can be built. The model building is carried out using computer graphic programs that display 
the electron density, allowing assignment and manipulation of protein backbone and amino acid 
residues. Several electron fitting and geometry refinement tools, as well as automated model building 
programs, greatly accelerate the process. Model building constitutes the most intense involvement of 
the crystallographer since chemical knowledge and previous experience on the field, are an 
advantage. Good phases and high resolution play a particularly decisive role in this important task 
[38, 43]. 
 
1.2.4 Resolution, Refinement and Validation 
There are a number of reliable indicators used to determine the accuracy of the atomic coordinates 
prior to publication in structural databases. Some come from the process of solving the structure and 
reflect the experimental data itself, others are derived from the obtained coordinates. The first simple 
indicator is the resolution of a structure, defined as the limit in diffraction angle, up to which X-rays 
diffracted by a crystal can be detected. Simplifying, the resolution is a measure of how much data 
were collected: the more data, the greater the ratio of the number of observations to the number of 
atomic coordinates to be determined, and usually the more accurate the results. The higher the 
resolution, the more detailed the electron density map. The average number of measurements per 
individual, symmetrically unique reflections is called redundancy or multiplicity. Since every 
reflection is measured with a certain degree of error, the higher the redundancy, the more accurate 
the final estimation of the averaged reflection intensity. After model building, the atomic model is 
“refined” by varying all model parameters to achieve the best agreement between the observed 
reflection amplitudes (Fobs) and those calculated from the model (Fcalc). Refinement is the adjustment 
of model parameters so that the calculated structure factors match the observations as nearly as 
possible, and this agreement is judged by the crystallographic “R-factor”. Every reported X-ray 
structure determination must include the statistical value R-factor (or R-work), which is simply a 
measure of how well the coordinates reproduce the experimental data. Also, the R-free parameter is 
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used to measure the agreement between the final model and the subset of experimental data retained 
for refinement. It corresponds to a little fraction of data (usually 5-10%), which is not used for the 
refinement process. This gives an unbiased measure of agreement. In good quality data the Rwork/ 
Rfree ratio should be around 20%. Another important parameter for crystallographers to judge their 
model is the B factor, which is related to the thermal vibration of an atom around its position. Thus, 
the higher the B factor the less defined (or more flexible) is that particular atom. The B factor 
parameter may be somewhat intuitive, but the most important criteria is that it should be within the 
same range of values for neighboring residues, revealing data consistency [38, 39, 43]. 
 
When analyzing a protein crystal structure, chemical parameters must also make sense, and must be 
in accordance with chemical constraints. Molecular chirality and stereochemistry must be obeyed, 
and deviations must make biological sense. The Ramachandran map provided by the graphic 
programs is a good guide for checking the conformations of + and , angles, the dihedral angles for 
the two degrees of freedom around the C$ atom of the amino acid residues, which define the fold for 
polypeptide chains. 
 
1.2.5 Synchrotron Radiation 
Although the majority of crystallographer’s all around the world possess an in-house X-ray machine, 
the introduction of synchrotron radiation (SR) facilities for routine use, constitutes a remarkable 
revolution in X-ray macromolecular crystallography. The basic fundamental function of a 
synchrotron is that it works as a storage ring, where electrons move around in a circle, almost at the 
speed of light through existing magnetic fields, generating intense X-rays, which can then be used 
for diffraction experiments. The common use of synchrotrons helps to explain the impressive high 
number of structures deposited each day in the PDB. The very slow process of data-collection in 
house, taking usually many days to conclude has been immensely shortened to a few hours or even 
less. Not only the speed of data collection, but also the data quality itself has been dramatically 
improved. Another important feature, due to the intensity and collimation of the beam in the 
synchrotron, is the possible use of ever-smaller crystals in the experiments. This is particularly 
important in the case of crystals that are hard to improve. We have regular access to SR by using 
some of the macromolecular crystallography beamlines available at the European Synchrotron 
Radiation Facility (ESRF) in Grenoble, France, namely ID14 and ID23 (Figure I. 9). This is one of 
the three largest and most powerful synchrotrons in the world (the other two are APS in USA and 
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Spring-8 in Japan). The crystal structures described in this Thesis were obtained from data collected 
at ESRF. 
 
 
Figure I. 9 – ESRF general overview (left), and schematic representation (right). 
 
With all the tools available nowadays, particularly the use of synchrotron radiation facilities, the 
available dispensing crystallizations robots for unlimited screening conditions and the emergence of 
more sophisticated equipment, such as fast X-ray detectors and computer processors, it is expected 
that protein crystallographers are tempted to “attack” proteins that have still remained a taboo for a 
long time. This will allow the number of macromolecular structures obtained by X-ray 
crystallography and deposited in the data bank to grow even more.  
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2  CHAPTER 2  
mouse Aldehyde Oxidase Homologue1 
 
 
 
 
 
 
 
Part of the work described in this chapter, was the subject of the following publication: 
 
M. Mahro*, C. Coelho*, J. Trincão, D. Rodrigues, M. Terao, E. Garattini, M. Saggu, F. Lendzian, P. 
Hildebrandt, M. J. Romão and S. Leimkühler (2011) “Characterization and crystallization of mouse 
Aldehyde Oxidase 3 (mAOX3): from mouse liver to E.coli heterologous protein expression”, Drug 
Metabolism and Disposition, published online ahead of printing. 
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2.1 INTRODUCTION 
Aldehyde oxidases (AO or AOX1, EC 1.2.3.1) are a small group of evolutionary conserved enzymes. 
Contrary to xanthine oxidoreductase (XOR), which constitutes the key enzyme in the catabolism of 
purines, converting hypoxanthine to xanthine and xanthine to uric acid, the physiological function of 
aldehyde oxidases is still largely unknown. However, the enzyme is known to play an important role 
in the metabolism of compounds with medicinal and toxicological interest [16, 18].  
 
Aldehyde oxidases oxidize R-H substrates using H2O and O2, which is the final acceptor of the 
reducing equivalents generated. Together with the resulting hydroxylation product (R-OH), 
superoxide anion radical is also produced (O2.-), which dismutates to form hydrogen peroxide (H2O2) 
(equation below). Both molecules can be potentially toxic for the cell, but can also be involved as 
defensive pathogenic agents. 
 
Typical AO substrates are compounds containing aromatic heterocycles (usually N-heterocycles) or 
aromatic aldehydes, which are oxidized into the corresponding carboxylic acid. From the main 
proposed substrates [16, 44], benzaldehyde, retinaldehyde (vitamin A precursor) and pyridoxal are 
among the most relevant ones (Table II. 1). AO is also known to catalyze the oxidation of 
intermediate products of cytochrome P450 (CYP), and there is evidence in the literature that liver 
AO can be considered as the CYP cytosolic equivalent [45]. There is a possibility that both enzymes 
act in concert, activating or inactivating various types of drugs and compounds with toxicological 
interest. The increasing importance of AO as a drug-metabolizing enzyme has been the subject of 
several publications, where an extensive list of compounds (particularly substrates and inhibitors) 
has also been theoretically tested [45, 46]. These studies have demonstrated that the most powerful 
AO inhibitor is raloxifene, a selective estrogen receptor modulator. Menadione is also reported as a 
specific inhibitor for aldehyde oxidase, and an interesting feature is that both compounds are 
ineffective in terms of XOR inhibition (Table II. 1) [45, 46].  
 
 30 
 
!"#$"%&'( )"*+( ,"-#%*.(
 
Benzaldehyde 
 
Substrate 
 
 
Retinaldehyde 
 
Substrate  
 
Pyridoxal 
 
Substrate 
 
 
Allopurinol 
 
Substrate 
 
 
Acridine 
carboxamide  
(DACA) 
 
Substrate 
 
 
Menadione 
 
Inhibitor 
 
 
 
Raloxifene 
 
 
Inhibitor 
 
 
7-hydroxy acridine 
carboxamide 
 
 
Inhibitor 
 
Table II. 1 – Relevant aldehyde oxidase substrates and inhibitors.  
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Xanthine oxidoreductases and aldehyde oxidases possess similar primary structures in various 
animal species, with 40% amino acid identity. They also share similar tertiary and quaternary 
structures, as the catalytically active forms are homodimers composed of two identical subunits with 
approximately 150 kDa each. The main physiological difference between the two enzymes is that 
XOR can exist in two interconvertible forms (XO and XDH), while AO exists only in the oxidase 
form. There is another difference regarding enzymatic function, since AO utilizes only molecular 
oxygen as electron acceptor, while XOR are able to transfer electrons not only to oxygen but also to 
nicotinamide adenine dinucleotide (NAD+) [16, 18, 47].  
 
It was known that in humans XOR and AO resulted from the expression of distinct genes residing on 
chromosome 2. A similar situation was thought to be true in the case of other vertebrates, but a few 
years ago the identification and characterization of novel murine genes, coding for different forms of 
aldehyde oxidase has changed this assumption [48]. While humans possess a single AO active gene, 
rodents have developed over three different genes (through a series of gene duplication events), 
coding for aldehyde oxidase homologue 1, 2 and 3 (mAOH1, mAOH2 and mAOH3), respectively. 
These aldehyde oxidase isoenzymatic forms are located on mice and rat chromosomes 1 and 9, 
respectively. Human and rodents aldehyde oxidases share 85% sequence identity, while 60% identity 
is found between the isoenzymatic forms and the human protein (Figure II. 1). One interesting 
feature is that the orthologous proteins from different organisms possess higher similarity than the 
homologous ones, present in the same organism. This may suggest that the gene duplication events 
occurred before species divergence [16, 17, 49].  
 
 
Figure II. 1 - General schematic representation of molybdo-flavoenzyme genes in vertebrates (Adapted from [50]). 
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Aldehyde oxidase homologues 1, 2 and 3 are expressed in different cell tissues, and the purpose of 
their existence is still puzzling. In rodents, the richest source of AOX1 and AOH1 is the hepatocyte 
component of adult liver. Expression of the two proteins is overlapping, but they differ as to the time 
of appearance in the liver of the developing mouse. The AOH1 transcript is readily detectable in 
newborn mice, while AOX1 appears later and is only measurable in the fully developed animal. 
Biochemical experiments demonstrated that the major source of mAOH2 is the harderian gland, 
which is the most important exocrine gland located in the intra-orbital cavity of rodents and other 
vertebrates. The other isoform, the mAOH3 protein, could only be detected in the bowman’s gland, 
the principal exocrine gland located in the sub mucosal layer of the nasal cavities, representing 
almost 5% of total cytosolic proteins. It was also observed that in rodents the aldehyde oxidase and 
aldehyde oxidase homologue1 activities are influenced by the gender, since significantly higher 
amounts of enzyme are present in male. This suggests that estrogens may regulate AOX1 and AOH1 
expression at the translational level, while androgens could exert transcriptional control. It is possible 
that gender specific regulation of these proteins by androgens and estrogens is an indirect effect 
mediated by other hormones or growth factors, as for instance the circulating growth hormone (GH) 
[48, 49, 51]. 
 
There is an increasing need to elucidate the main features, which dictate the specificity for the 
various aldehyde oxidase isoforms. These studies can only be possible with the expression of 
recombinant protein in heterologous systems, particularly due to the limited amounts of protein 
available from the native sources, and also to enable mutagenic studies. The chemical structure of 
MoCo in prokaryotes is different from that found in eukaryotes, preventing assembly of the holo-
enzyme in engineered bacteria. With the introduction of genetic modifications in the host bacteria for 
eukaryotic MoCo synthesis, the authors Mahro and Schumann were able to express and purify 
recombinant mouse AOH1 and AOX1 proteins respectively [52, 53]. This breakthrough helped to 
produce sufficient amount of protein for biochemical and structural studies, which may be useful in 
providing some answers to the questions related with this family of proteins. Besides, it can also help 
to understand the possible importance and involvement of human aldehyde oxidase in the field of 
diseases such as obesity and cancer. Recent data support the idea that this enzyme plays a positive 
role in adipocyte differentiation. The specific tissue aldehyde oxidase expression could be explored 
to design novel anti-cancer drugs or even strategies to achieve organ and/or tumor selectivity [15, 
54]. 
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Until recently, and due to the absence of a three-dimensional structure for an aldehyde oxidase 
protein, in silico studies have been carried out based on model comparison with the XOR protein, 
whose crystal structure was reported in 2000 by Nishino and collaborators [13]. The system now 
available for producing enough quantity of the heterologous mAOH1 protein, allowed obtaining 
suitable crystallization conditions, which were later successfully reproduced with the native mouse 
protein [52]. The crystal structure of mAOH1 was solved by molecular replacement, and is the focus 
of this chapter. This constitutes the first three-dimensional structure for an aldehyde oxidase, and has 
been used for detailed comparisons with other enzymes of the xanthine oxidase family, providing the 
molecular details for the distinct specificities between the different enzymes (XORs and AOs). Also, 
comparison of the structural characteristics of the different forms within the same species (such as 
AOX1 and mAOH1) can help to predict if they metabolize the same or different substrates. The role 
of mammalian aldehyde oxidases in the activation or inactivation of foreign drug compounds can 
also be explained. Due to its unique distribution and substrate specificities, aldehyde oxidase has 
been recently recognized as an enzyme with an important role in the metabolism of drugs and 
xenobiotics, and has therefore high pharmacological relevance [15, 45]. 
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2.2 EXPERIMENTAL PROCEDURE  
2.2.1 Purification of AOH1 from Mouse Liver 
To purify the native mouse aldehyde oxidase homologue1, 135 CD-1 mice were purchased from 
Charles Liver Laboratory (Como, Italy) and kept at 25ºC with a 12h light/dark cycle in the “Mario 
Negri” Institute animal house facilities (Milan, Italy). Unless otherwise stated, all purification steps 
were carried out at 4ºC. The mouse livers (35-40 g) were homogenized in three volumes of 100 mM 
sodium phosphate buffer, pH 7.5 using an Ultraturrax homogenizer (Omni 2000-Waterbury, CT). 
Homogenates were centrifuged for 45 min at 100,000 x g to obtain the cytosolic extracts, which were 
later heated for 10 minutes at 55°C, and again centrifuged to remove precipitated proteins. An equal 
volume of saturated ammonium sulfate solution was added to the supernatant, and incubated 
overnight.  The resulting precipitate was collected by centrifugation and resuspended in 100 mM 
Tris-Glycine pH 9.0. The solubilized proteins were mixed with benzamidine Sepharose (Amersham 
Biosciences, Sweden) pre-equilibrated with sample buffer, and incubated for 2 hours. The resin was 
washed with 4 x 10 ml equilibrating buffer and the absorbed protein eluted using 5 mM 
benzamidine. After buffer exchange to 50 mM Tris-HCl pH 7.4, the sample was loaded on a 5/5 
FPLC Mono Q column (Amersham), and mAOH1 eluted with a linear gradient 0-1M NaCl. The 
protein was concentrated to 10 mg/ml in 50 mM Tris-HCl, pH 7.4, and stored at -80ºC. 
 
2.2.2 Expression and Purification of mAOH1 from E.coli  
The protein heterologous expression system was developed by Martin Mahro, at the “Institut für 
Biochemie and Biologie” (Potsdam, Germany). E.coli TP1000 (-mobAB) cells were used for the co-
expression of mAOH1 wild-type with mMCSF (pSS110), and the cultures were grown aerobically in 
LB medium at 30°C for 24h. The mAOH1 cDNA from mouse CD1 liver was cloned using primers 
designed to permit cloning into the NdeI and SalI sites of the expression vector pTrcHis. The 
resulting plasmid was designated pMMA1 and expresses mAOH1 as an N-terminal fusion protein 
with a His6-tag. pMMA1 and pSS110 were transformed into TP1000 cells. To express the 
recombinant protein, cells were grown in LB medium supplemented with 150 .g/ml ampicillin, 50 
.g/ml chloramphenicol, 1 mM molybdate, and 10 .M IPTG, at 30°C. After 24h the cells were 
harvested by centrifugation and resuspended in 50 mM sodium phosphate buffer pH 8.0, 300 mM 
NaCl. DNaseI and lysozyme (1 mg/L) were added to disrupt the cells at 12°C and 1.35 kbar 
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(Constant Cell Systems TS Benchtop Series). The cleared lysate was loaded onto a Ni2+ column (Ni-
NTA, Qiagen), and mAOH1 eluted with 250 mM imidazole. Buffer was exchanged to 50 mM 
potassium phosphate, pH 7.8, 0.1 mM EDTA using PD10 columns (GE Healthcare). To increase the 
activity of the enzyme, chemical sulfuration was performed [55, 56]. The purified enzyme was 
incubated with 500 .M sodium dithionite, 25 .M methylviologen and 2 mM sodium sulfide, for 1 
hour in an anaerobic chamber (Coy Lab Systems). After buffer exchange to 50 mM sodium 
phosphate, pH 8.0, 300 mM NaCl, the sample was loaded onto a Superose 6 column (GE 
Healthcare), and fractions containing dimeric mAOH1 were combined and stored in 100 mM 
potassium phosphate pH 7.4, at -80°C. 
 
To cleave the N-terminal His6-tag, mAOH1 was incubated with 50 mM Tris-HCl pH 8.0 and 1mM 
EDTA, at 4ºC for 12 hours. Thrombin cleavage site introduced by pTrc-His was used, and the 17 
residues His6-tag was cleaved after Arg17 [57]. The protein was loaded onto a HiLoad 26/60 
Superdex 200 column (GE Healthcare), equilibrated with 50 mM sodium phosphate pH 8.0, 300 mM 
NaCl. Fractions containing dimeric /His6-mAOH1 were combined and concentrated to 17.8 mg/ml, 
by ultrafiltration (Amicon). Protein aliquots were frozen in liquid nitrogen and stored at -80°C until 
usage, without loss of activity.  
 
Using PCR mutagenesis, the amino acid exchange Y885M was introduced into the mAOH1 
recombinant protein. The generated variant was expressed and purified using the same conditions as 
previously mentioned for the wild type form of the enzyme. After purification, the Y885M variant 
was concentrated to 17.8 mg/ml and stored in 100 mM potassium phosphate pH 7.4, at -80°C until 
necessary. 
 
2.2.3 Protein Crystallization 
The first crystallization trials were performed using the native mAOH1 purified from male mouse 
livers. Using this protein, more than 800 different conditions were tested, at three different 
temperatures (4, 15 and 20ºC) but no successful results were obtained. In addition, the limited 
amount of protein obtained (9.4 mg) restricted additional crystallization trials. The recombinant 
mAOH1 yielded larger amounts of pure protein that allowed pursuing the crystallization studies and 
including more variables, such as incubating the protein with DTT and using several additives. The 
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first crystals appeared using the recombinant protein incubated with a freshly prepared DTT solution, 
polyethylene glycol (PEG) 4000 and 8000 as precipitant and Tris-HCl as buffer, at 20ºC. Under these 
conditions long thin needles were obtained, but were unsuitable for diffraction experiments and 
needed to be improved (Figure II. 2-a). Several additives were tried in order to optimize the needle-
shaped crystals, using commercially available additives as well as some known mAOH1 inhibitors 
(e.g. menadione). Another less conventional approach using the ionic liquids [C4mim] Cl- (1-butyl-3-
methylimidazolium chloride) and [C4mim] MDEGSO4, (1-butyl-3-methylimidazolium 2(2-
methoxyethoxy) ethyl sulfate) 0.2, 0.4 and 0.6 M (final concentration in the protein solution) was 
also attempted. In a similar case of crystal optimization, this proved to be a very attractive alternative 
(Chapter 4 of this Thesis). Nevertheless, this approach did not improve the mAOH1 crystals. Further 
extensive trials included small variations in the initial conditions, such as changing the buffer and 
precipitate concentration. The best protein needles of recombinant mAOH1 were obtained using 12-
16% PEG 8000 as precipitant and 0.1M potassium phosphate pH 7.0 at 20ºC. Using the hanging drop 
vapor diffusion method, equal amounts of protein (17.8 mg/ml) and precipitant solution were mixed, 
after incubating the protein with fresh DTT at 4ºC for at least 1h (final DTT concentration in the 
protein solution was 8mM).  
 
In parallel, another strategy was followed in an attempt to try to improve the crystals of the 
recombinant protein that consisted in cleaving the protein His6-tag (which added 17 amino acids to 
the protein). His-tags usually have little effect on the native structure of a protein, but can have an 
impact in crystallization. We tested if this was the case for the recombinant mAOH1 [58]. Although 
crystals were also formed under similar conditions as the protein with the His6-tag (14% PEG 8000, 
0.1M potassium phosphate pH 7.00 and spermine tetra-HCl as additive) no significant improvement 
was achieved. The best diffraction obtained for crystals from the untagged recombinant protein, was 
around 6Å at PXI beamline at Swiss Light Source (SLS, Villigen, Switzerland), and the crystals were 
very difficult to reproduce. 
 
Using a remaining amount of native mAOH1 isolated from the mouse liver, similar crystallization 
conditions were tested. The buffer pH for the mouse protein was optimized to 6.5 (instead of 7.0), 
the protein concentration used was 10 mg/ml, and 2mM EDTA was added to the crystallization 
solution. Larger, two dimensional rectangular-shaped crystals (0.40 x 0.15 x 0.05 mm3, Figure II. 2-
b) of the native mAOH1 were reproducibly formed. These were the only crystals that allowed 
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collection of a usable diffraction data set. The same conditions were also used for crystallization of 
the variant Y885M, and nice crystals grew within 3 days (Figure II. 2-c). Although these crystals 
looked much better in terms of size and morphology than the native recombinant ones, diffraction 
was also poor. 
 
Figure II. 2 - Crystals of mAOH1 protein: (a) needles from the recombinant protein; (b) crystals from the native mouse 
liver protein; and (c) crystals from the Y885M variant. 
 
2.2.4 Data Collection, Processing and Structure Solution 
All tested crystals were flash-cooled directly in liquid nitrogen, using paratone oil as cryoprotectant, 
before transfer to a gaseous nitrogen stream for data collection. Several cryoprotectant solutions 
containing glycerol (30%) and higher PEG concentration (20%) were also tested. Some of the tested 
native mAOH1 crystals diffracted to ~6Å but, after annealing (using the beamline’s automated 
annealing procedure), diffraction improved considerably to a resolution beyond 3Å. A first data set 
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(mNAT-I) consisting of 180º of data was collected at ID14-1 from the European Synchrotron 
Radiation Facility (ESRF, Grenoble, France), at a wavelength of 0.934Å on an ADSC Q210 detector 
(Figure II. 3). The crystal belonged to space group P1, with unit cell dimensions a = 91.07 Å, b = 
135.02 Å, c = 147.48 Å, ! = 78.27º, " = 77.77º and # = 89.96º. The calculated Matthews coefficient 
was 2.89 Å3Da-1, corresponding to two dimers in the unit cell with a solvent content of 57.4 % 
(Table II. 2) [42]. Because the data were very anisotropic and the mosaicity was high, the initial data 
processing using imosflm 1.0.4 was incomplete (~89% complete to 2.9Å) [59]. The mosaicity value 
had to be maintained fixed because refinement during integration was unstable and led to crashing of 
the program. The same crystal was later measured at ID23-1 (&=0.9748Å), again at the ESRF. 
Although a full 360º of data were collected, only about 220º were useable (mNAT-II) because the 
crystal was very anisotropic. This data set was worse than the first one, and even though the 
multiplicity was higher, the completeness was very low (~60% to 3Å) (Table II. 2). The two data sets 
were merged together in order to increase the completeness and improve the multiplicity. This 
dataset presents a very high Rpim and is only ~80% complete to 2.9Å (NATmerged), but the overall 
redundancy improved to ~3.0. The structure of the mAOH1 was solved by molecular replacement 
using BALBES on the mNAT-I data set [60]. The bovine milk XDH structure with a covalently 
bound oxipurinol inhibitor (PDB code 3BDJ) was used as a search model [61]. Four monomers were 
found in the unit cell, yielding a Matthews coefficient of 2.89 Å3/Da-1, corresponding to a solvent 
content of 57.4%. 
 
 
Figure II. 3 - Diffraction pattern of the native mouse liver AOH1: (a) obtained at ID14-1 (in the upper left quadrant after 
re-annealing); (b) and at ID23-1 (ESRF). Resolution at the edge is 3.0Å. 
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Crystal Sample mNAT-I mNAT-II NATmerged 
X-ray source ID 14-1 ID 23-1 - 
Crystal system Triclinic 
 
Unit-cell parameters  
(Å, º) 
a = 91.07, b = 135.02,  
c = 147.48 
$ = 78.27, % = 77.77,  
" = 89.96 
a = 91.54, b = 135.83, 
 c = 147.84 
$ = 78.22, % = 77.89,  
" = 89.97 
 
 
- 
Maximum resolution (Å) 2.9 3.0 3.0 
Mosaicity (º) 1.0 1.0 1.0 
Molecules per ASU 4 
Matthews coefficient 
(Å3/Da) 
 
2.89 
 
2.93 
 
- 
Space group P1 
Wavelength (Å) 0.934 0.975 - 
No. observed reflections 219268 (20892) 223954 (24999) 338761 (41810) 
No. unique reflections 133319 (16784) 78529 (10857) 112209 (16428) 
Resolution limits (Å) 51.1 – 2.9 50.0 – 3.2 50.0 – 3.20 
Redundancy 1.6 (1.2) 2.8 (2.2) 3.0 (2.5) 
Completeness (%) 89.8 (77.3) 69.5 (65.1) 81.8 (81.7) 
Rpim (%) 5.6 (14.0) 14.3 (68.9) 17.5 (63.4) 
I / ) (I) 9.6 (3.6) 6.3 (1.4) 7.0 (4.2) 
Table II. 2 - X-ray crystallography data-collection statistics. (Values in parenthesis correspond to the highest resolution 
shell) 
 
2.2.5 Model Building and Refinement 
Initial protein model was manually built in Coot [62] and refined using phenix.refine [63]. Initial 
refinement cycles were carried out using simulated annealing. Because of the low resolution (2.9Å) 
and incomplete dataset (low data/parameter ratio), 4-fold NCS restraints, consisting of the 4 copies in 
the A.U., were imposed. Also, only one B-factor per residue was refined throughout the process. TLS 
was also used in the refinement, with the TLS groups automatically calculated by phenix. Currently, 
the Rfactor and Rfree values are 24.40% and 27.87% respectively, before addition of water molecules. 
Structure refinement data is present in Table II. 3. Final model included the following amino acid 
residues: Ser7 – Val1334. There are also some regions with no visible electron density, particularly: 
Pro169 - Thr199, Glu227 – Asn231, Gly399 – Ile404, Asp538 – Ile545, Leu558 – Gly563, Arg1290 
– Trp1296, and Gln1321 – Pro1329. 
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Crystal Sample mNAT-I 
Resolution limits (Å) 51.1 – 2.9 
Number of reflections 
 
133319 
 
Rwork (%) a 24.40 
Rfree (%) b 27.87 
RMSD from ideal geometry 
Bond lengths (Å) 
Bond angles (o) 
 
0.020 
1.82 
Average B-factor (Å 2) 41.10 
Ramachandran outliers (%) 0.3% 
Ramachandran favored (%) 93.6% 
 
 
Table II. 3 – Structure refinement data.  
aRwork = 0 ||Fcalc| - |Fobs||/ 0 |Fobs| x 100, where Fcalc and Fobs are the calculated and observed structure factor amplitudes, 
respectively. (bRfree is calculated for a randomly chosen 5% of the reflections). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 41 
 
2.3 RESULTS AND DISCUSSION 
The aldehyde oxidase homologue1 (mAOH1) was purified from mouse liver and from a 
heterologous expression system in Escherichia coli, and the resulting enzymes were compared. Both 
proteins show the same catalytic properties and characteristics, with the exception that the 
recombinant protein is only 30% active, while the native is 100%. Additionally, both proteins were 
crystallized and the best crystals were obtained from the native mAOH1 (Figure II. 2). These crystals 
diffracted beyond 2.9Å at the ESRF (Grenoble), and belong to space group P1 with two dimers 
present in the asymmetric unit (Table II. 2) [52].  
 
2.3.1 Overall Structure Description 
Mouse aldehyde oxidase homologue1 is a homodimer, composed of two identical subunits with 
approximately 150 kDa (Figure II. 4-a). Each monomer comprises 1335 residues and is divided in 
three main domains, classified according to their involvement in binding the distinct cofactors. 
Domain I is the N-terminal domain and the smallest one (20 kDa). It harbors the two 
spectroscopically different iron-sulfur clusters and comprises residues Met1-Pro169 (Figure II. 4-a, 
red). Domain II binds the FAD cofactor, has an approximate molecular size of 40 kDa, and includes 
residues Thr232-Leu534 (Figure II. 4-a, green). The C-terminal domain, is the largest one (90 kDa), 
encloses the MoCo (molybdopterin monophosphate, MPT) binding site and corresponds to residues 
Leu576-Val1335 (Domain III, Figure II. 4-a, blue). The Mo catalytic center is located at the bottom 
of a hydrophobic pocket accessible from the exterior trough a wide funnel ~15Å long. The distance 
from the pterin exocyclic NH2 to the nearest atom of [2Fe-2S] II center is 5.1Å (Figure II. 4-b). The 
cofactor disposition in the protein is related with the electron transfer pathway. When the oxidative 
hydroxylation occurs at the Mo catalytic center, the released electrons can pass consecutively 
through the two iron-sulfur-centers until they reach the FAD redox cofactor, and from there to the 
final electron acceptor, O2. The three domains are connected by two linkers: domain I and II by a 
poorly conserved linkerI region (Ser170 to Asn231), and domain II and III by linkerII (Lys535 to 
Pro575) (Figure II. 4). 
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The N-terminal Iron/Sulfur Domain 
The two iron–sulfur clusters are located in domain I, and are designated [2Fe-2S] I and II, according 
to their distinct EPR signals.  Domain I can be sub-divided in two subdomains, the N-terminal sub-
domain (residues Met1-Val92) which harbors the [2Fe-2S] II and has a typical plant-type ferredoxin 
like fold, with one $-helix and five stranded %-sheets [14]. Fe/S II is bound via a Cys47-X4- Cys52-
Gly-Ala-Cys55-X21-Cys77 motif. The second helical sub-domain (residues Glu93-Pro169) has a 
twofold symmetric arrangement, and binds the [2Fe-2S] I via the highly conserved Cys117-Gly-Phe-
Cys120-X31-Cys152-Arg-Cys154 motif [13, 14]. The nearest Fe atoms from the two different Fe/S 
centers are 12.4Å apart from each other. The closest distance between [2Fe-2S] II and the 
molybdopterin cofactor is 5.1Å, while [2Fe-2S] I is approximately 9Å away from the FAD cofactor 
(Figure II. 4-b). 
 
Figure II. 4 - (a) Ribbon representation of mAOH1 crystal structure. Monomer B in grey (left), and monomer A showing 
the different domains (right), colored as: domain I in red (residues Met1-Pro169); domain II in green (residues Thr232-
Leu534); and domain III in blue (residues Leu576-Val1335). The linker regions are represented in grey (linker I and II, 
respectively Ser170-Asn231, and Lys535-Pro575). The molybdopterin monophosphate (MPT), [2Fe-2S] and FAD 
cofactors are shown as sticks and colored by atom type. (b) Arrangement and distances between the different protein 
cofactors: MPT, the two distinct [2Fe-2S] centers, and FAD. 
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The FAD Domain 
The flavin adenine dinucleotide (FAD) cofactor is part of domain II, which can be subdivided in two 
different sub domains spanning from Thr232 to Arg419, and from Lys 420 to Lys534, respectively. 
The FAD cofactor is mainly coordinated by the first sub domain. Residues Pro263, Leu264, Asn268, 
Thr269, Tyr270, Ser354 and Leu411 make hydrogen bonds with the adenine dinucleotide region, 
while residues His358 and Asp367 contact the riboflavin ring. From all these residues, only the 
residues Thr269 and Asp367 are highly conserved among other XO family members (Figure II. 5). 
The second sub domain is in the MoCo domain side, and contains three long %-sheets and two $-
helices. The FAD molecule occupies a vast area within the protein, with the isoalloxazine ring in 
close proximity to the solvent area. The riboflavin ring is pointing towards Fe/S I center (Figure II. 
4-b).  
 
The C-terminal Catalytic Domain 
The C-terminal and largest domain (Domain III - 90 kDa) contains the MoCo binding site, which is 
located on the bottom of the substrate binding pocket. It can be structurally divided in four sub-
domains, classified as for MOP and XO [13, 14]. Each sub domain is constituted by non-continuous 
stretches of the polypeptide chain: sub domain III.1, comprises residues 576-698 and 745-843; sub 
domain III.2, residues 699-744, and 844-964; sub domain III.3 possess residues 965-1009, plus 
1160-1354; and finally, sub domain III.4 is constituted by residues 1010-1159. All these sub domains 
have a similar fold, with two central $-helices covered by three to five %-sheets, solvent exposed in 
the case of sub domains III.2 and III.3, and involved in dimerization contacts in sub domains III.1 
and III.4. The molybdopterin monophosphate cofactor is buried in the protein, and forms hydrogen 
bonds with residues Ala802, Arg917 (highly conserved among XO family members, Figure II. 5), 
Leu1043, Ser1085 and Gly1087. The molybdenum atom is found at the bottom of a wide funnel 
(20Å wide at the surface), dominated by the presence of hydrophobic residues, which leads to the 
active site (Figure II. 10).  
 
Figure II. 5 - Comparison of the amino acid sequence of mAOH1 with XOR from bovine milk, with XDH from 
R.capsulatus and MOP from D.gigas. The mAOH1 [2Fe-2S] I and II binding Cys residues are marked as (*) and (+) 
respectively. Black boxes indicate identical residues, and grey similar ones. Alignment results obtained with 
CLUSTALW multiple sequence alignment program at the EMBL-EBI web server, and the figure prepared using 
BOXSHADE from EMBnet server. 
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2.3.2 The Homodimer 
The overall topology of mAHO1 is similar to the mammalian xanthine dehydrogenase protein 
(XDH), a typical butterfly shape structure with approximate dimensions of 150Å x 90Å x 70Å 
(Figure II. 4). The two monomers are tightly bound, involving 23 hydrogen bonds (< 3.2Å) and 12 
salt bridges. The majority of these bonds are established by residues from domain III, the MoCo 
binding domain. Particularly residues: Lys759, Glu761 and 764, Lys789, Asn790 and 793, Lys797, 
Arg798 from sub-domain III.1, and residues Gln1021, Ile1028, Thr1030, Asp1031, Ser1033, 
Val1034, Asp1069 and Asn1078 from sub-domain III.4. The surface contact area between the two 
subunits is 2500Å2, approximately 5.3% of the total surface area of each monomer. The 
molybdenum atoms from the two different monomers are more than 50Å apart and the two subunits 
most likely act independent from each other. 
 
2.3.3 Comparison with Structurally Related Proteins 
The mAOH1 structure reported in this Thesis is the first crystal structure ever obtained for an 
aldehyde oxidase. However, several protein structures from the XO family have already been 
reported. The most interesting feature among these different proteins is the similar overall globular 
shape, while catalyzing different reactions with a wide range of substrates. The first crystal structure 
was reported in 1995, for the prokaryotic D.gigas aldehyde oxidoreductase (MOP) that was solved at 
2.25Å, and later refined to almost atomic resolution (1.28Å) [14, 64]. MOP oxidizes aldehydes to 
carboxylic acids, with little specificity for the nature of the side group. Despite the low 
correspondence in sequence identity (23%, Figure II. 5), the overall fold of MOP is similar to 
mAOH1, in domains I and III, since MOP lacks the FAD domain and has only 907 amino acid 
residues (Figure II. 6). Also, the two [2Fe-2S] centers are similarly positioned in both MOP and 
mAOH1, and many of the residues proximal to the clusters are either identical or type conserved. 
 
The crystal structures of bovine milk xanthine dehydrogenase (XDH) and its interconvertible form 
xanthine oxidase (XO) were first reported in 2000 [13]. The crystal structure of the XDH isolated 
from the purple bacterium Rhodobacter capsulatus (Rc) was also solved, and published in 2002 [65]. 
While the bovine XDH/XO is a homodimeric enzyme with ~1300 amino acid residues in a single 
polypeptide chain, the R.capsulatus XDH has an ($%)2 heterotetrameric structure, with molecular 
mass of 275 kDa. In the latter enzyme, the cofactors are located on different polypeptide chains, with 
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the two [2Fe-2S] clusters and the FAD bound to the XdhA subunit, and the MoCo cofactor located in 
the XdhB subunit. For an easier comparison, each mAOH1 monomer (that includes the three 
different cofactors) can be considered as equivalent to one Rc XDH heterodimer. The mAOH1 and 
the Rc XDH structures superimpose with an rms deviation of 1.09Å for 913 C$ atoms. Despite the 
different subunit composition, the overall fold as well as cofactors arrangement of mAOH1 and Rc 
XDH is similar, with both proteins sharing 32% sequence identity. However, there are some 
differences that can be noticed in the primary sequence alignment (Figure II. 5). The linker II region 
(residues 535 to 575, between the FAD and MoCo domains) present in AOH1 and XDH/XO is 
absent in the bacterial enzyme. Two other clear differences, easily seen in the structures 
superposition (Figure II. 6), result from the insertions of 20 and 19 amino acid residues, in the 
regions Arg953-Thr954 and Pro1114-Ser1115, respectively (mAOH1 numbering). These two 
regions are located at the MoCo binding domain and solvent exposed, and the Arg953-Thr954 
sequence is at the XDH heterotrimer interface. The two insertions protrude out of the globular 
protein surface (marked with arrows in Figure II. 6).  
 
The several cofactors are localized in similar positions in the four enzymes, and provide equivalent 
electron transfer pathways (Figure II. 6). 
 
Two important aspects must be addressed at this point. The XDH from R.capsulatus possess high 
reactivity towards NAD+, as in the case of bovine XDH, and does not undergo conversion to the 
oxidase form, as observed for the mammalian XDH/XO (explained below). The MoCo analysis of 
Rc XDH revealed the presence of the molybdopterin cofactor monophosphate form (MPT) as found 
in the eukaryotic MoCo containing enzymes (Figure II. 6). This was not expected, since the majority 
of MoCo containing bacterial enzymes (as MOP) have the MCD form (Figure II. 6), with an 
additional cytosine nucleotide covalently attached to the pterin [65]. 
 
 
 
Figure II. 6 - Comparison between mAOH1 (blue) and the different crystal structures obtained for the XO family: (a) 
aldehyde oxidoreductase from D.gigas (MOP monomer – yellow, PDB code: 1VLB), (b) xanthine dehydrogenase from 
R.capsulatus (Rc XDH - red, PDB code: 1JRO), (c) xanthine dehydrogenase from bovine milk (XDH milk - green, PDB 
code: 1FO4). Next to each structure comparison is the superposition of the cofactors involved in electron transfer 
(mAOH1 –atoms color coded, MOP in yellow, Rc XDH in red, and XDH milk in green). 
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2.3.3.1 Mammalian XOR Inter-conversion and mAOH1 
Mammalian xanthine oxidoreductases (XOR) are synthesized in the dehydrogenase form, but can be 
readily converted to the oxidase form by two different mechanisms: oxidation of sulfhydryl residues, 
and proteolysis [13]. The enzyme exists in two alternative forms (XDH and XO) of the same gene 
product. The global fold of both proteins remains essentially the same after the inter-conversion 
XDH!XO, with an rms deviation in C$ positions of 0.30Å for 1095 atoms. The general 
conservation of the structure is consistent with biochemical studies, and no major differences 
regarding binding and catalysis of substrates are observed at the molybdenum catalytic center in both 
protein forms. The main difference is the binding of the cofactor NAD+, which occurs in the XDH 
but not in the XO form. This has implications in structural terms, with differences between the two 
forms at a loop region (see below). In XO, molecular oxygen acts as the electron acceptor, as in the 
case of mAOH1.  
 
When comparing bovine milk XDH and mouse AOH1 crystal structures (Figure II. 6 - c), we can see 
that their global fold as well as cofactor arrangement is very similar (rms deviation of 1.26, for 2358 
C$). The major difference between the two proteins concerns important residues located not only at 
the active site (section 2.3.4), which explains the differences regarding substrate specificities, but 
also residues involved in the XOR mechanisms of inter-conversion. This kind of mechanisms has 
never been described for aldehyde oxidases. The reversible XDH !XO conversion mechanism 
involves the oxidation of two different cysteine residues (Cys535 and Cys992, bovine XDH 
numbering), and the formation of a new disulfide bond. These two cysteine residues are not 
conserved in mAOH1, corresponding to Tyr542 and Phe997 respectively. Tyr542 could not be 
assigned in the mAOH1 electron density map, but Phe997 locates in the protein surface, pointing 
towards the solvent.  
 
XDH can also be irreversibly converted to XO by proteolysis and in both cases (oxidative and 
proteolytic generation of XO) there is a structural rearrangement on a loop close to the FAD ring. 
This “moving loop” is constituted by residues Gln423-Lys433 (bovine XDH numbering), and its 
displacement causes partial blockage of the NAD+ molecule towards interaction with the FAD 
cofactor (Figure II. 7). As a result, the XO form does not bind NAD+ and uses oxygen as electron 
acceptor. As well as the “moving loop” displacement, there is the removal of a phenylalanine residue 
(Phe549, bovine XDH numbering) from a tightly packed amino acid cluster, causing major 
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reorientation of a tryptophan residue (Trp336 in bovine XDH) (Figure II. 7– a). This residue is 
located at the entrance of a tightly closed cavity leading to the FAD cofactor, and its movement 
opens the cavity causing FAD solvent exposure, particularly in the isoalloxazine ring (around C4-C6 
positions). As a result of these two different displacements (Gln423-Lys433 loop and Trp336, XDH 
numbering) there is a change in the FAD cofactor electrostatic environment, which accounts for the 
main differences between XDH and XO forms regarding nicotinamide adenine dinucleotide binding 
[13, 66].  
 
Figure II. 7 - Representation of the “moving loop” (residues Gln423-Lys433, in bovine XDH numbering) and important 
residues involved in the XDH/XO conversion. (a) Residues Phe549, Trp336 and the original loop position in bovine 
XDH (green). (b) Comparison between mAOH1 (blue) and bovine XDH (green), concerning the “moving loop” and 
Trp336 from XDH (which corresponds to Thr343 in mAOH1). The “moving loop” is mainly constituted by highly 
charged residues (QASRREDDIAK) in XDH, which are replaced by lesser-charged ones in mAOH1 (QAPRQQNAFAT) 
(the 4 conserved residues are underlined). (c) Differences observed in the loop and in residue Trp336 after the 
XDH!XO conversion (XDH in green, and XO in orange). (d) Same as in (c) but from a different perspective, outlining 
the differences between the “moving loop” from XO (in orange), and the mAOH1 and XDH structures (blue and green, 
respectively). All the FAD cofactors are represented color coded, and correspond to the mAOH1 structure.  
 50 
 
In mAOH1, the corresponding “moving loop” is superimposable with the one observed in the XDH 
form, although only 4 out of 11 residues are conserved between the two proteins (Figure II. 7- b). 
However, as previously mentioned aldehyde oxidase does not bind the NAD+ cofactor, using oxygen 
as the electron acceptor. The mAOH1 protein should therefore be more similar to the XO form than 
to XDH, since they possess the same electron acceptor. Nevertheless, xanthine oxidoreductase 
naturally occurs in the dehydrogenase form, and in the absence of an inter-conversion form described 
for AO, it is not surprising that the protein shows higher similarity towards the natural XDH form. 
The inexistence of an AO inter-conversion form could be related with some of the differences 
described previously.  
 
XOR inter-conversion has been described by some authors to be connected with milk lipid secretion 
[67], but other opinions defend that it is involved in human ischemic-reperfusion injury defense 
mechanisms, due to the higher formation of radical oxygen species during the XO form catalytic 
reaction [67, 68]. 
 
2.3.4 mAOH1 Catalytic Active Site and Substrate Funnel 
At the present resolution (2.9Å) it is not possible to identify the chemical nature of all the atoms 
bound to molybdenum, based on electron density alone (Figure II. 8). Two of these ligands are the 
sulfur atoms from the dithiolene moiety, which in mAOH1 are located in Mo-distances ranging from 
2.4 to 2.7Å (for the 4 molecules in the a.u.). The exact nature of the three other ligands must be 
based on crystallographic data for the related XOR [13, 14, 69]. In the oxidized form of the active 
enzyme, the Mo coordination sphere should include an essential catalytic sulfur atom (=S), an apical 
oxygen atom (=O), and an equatorial OH group. This single bonded oxygen atom is pointing towards 
the active site funnel and is later transferred to the substrate. The five different ligands form a square 
pyramidal geometry. 
 
With the mAOH1 structure firstly reported here, we are able to take a closer look at the protein 
active site, and draw some conclusions regarding its broad range of substrates. Several 
pharmaceutical companies have given their attention to aldehyde oxidases in recent years. It has been 
recognized that through its unique structure, distribution and substrate recognition, this protein has a 
vital role in drug metabolism, despite the lack of knowledge regarding biochemical and physiological 
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function. It is imperative now to understand all these specificities, located mainly at the protein 
active site. 
 
Figure II. 8 - Close-up of the MPT and Mo coordination sphere, for the mAOH1 monomer A.  
(2mFo-DFc electron density map contoured at 1), blue). 
 
Typical aldehyde oxidase substrates are compounds containing an aldehyde function, nitro/nitroso 
compounds or N-heterocycles (Table II. 1), while hypoxanthine and xanthine are XOR elected 
substrates. When comparing mAOH1 and bovine milk XDH structures, the most important residues 
conserved at the active site are the ones located up and down relative to the Mo atom (Gln772 and 
Glu1266) and two Phe responsible for maintaining the XDH salicylate inhibitor in place (Phe914, 
and Phe 1009). In XDH, the aromatic ring of Phe914 is parallel to the inhibitor molecule, while 
Phe1009 has an edge-on interaction. The two Phe are conserved in mAOH1 (Phe919 and Phe1014), 
making the model interaction of bicyclic substrate also possible. The mAOH1 Glu1266 residue 
(Glu1261 in bovine XDH and totally conserved in all members of the XO family) is also included in 
these conserved residues, and is responsible for playing a fundamental role in the reaction 
mechanism, as explained below. 
 
Other important residues located at the catalytic core are in general not conserved between the two 
proteins, and this explains the differences regarding binding and catalysis. Particularly, residues 
Glu802, Arg880 and His884 (in bovine XDH numbering), which are replaced by Ala807, Tyr885 
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and Lys889 in mAOH1, respectively, are crucial for the different proteins specificities. Glu802 from 
bovine XDH is replaced by an aliphatic and smaller residue in mAOH1, Ala807 residue, which 
allows the active site to accommodate larger and bulkier substrates. Also the presence of a less 
charged residue contributes to the necessary environment for the binding of more charged 
compounds as seen in mAOH1. In bovine XDH another important residue, Arg880, is responsible 
for the correct positioning and maintenance of the salicylate and oxipurinol inhibitors (represented in 
Table II. 4 and Figure II. 9, respectively). This position is occupied by the aromatic ring of a tyrosine 
in mAOH1 (Tyr885) pointing outwards from the molybdenum atom and again increasing the 
mAOH1 active site availability for accommodating larger substrates. The mAOH1 Lys889 residue, 
although being almost 10Å away from the molybdenum center, makes also a decisive contribution in 
the protein catalytic core. This residue (conserved in other AOs) corresponds to His884 in bovine 
XDH, a bulky residue located in the active site funnel pathway, limiting the access of large substrates 
to the protein catalytic center. All these differences account for the binding of the distinct XOR and 
AOH1 substrates, particularly the substitution of smaller residues in the aldehyde oxidase protein 
(Figure II. 9). 
 
Figure II. 9 – Active site comparison between mAOH1 (yellow) and bovine XDH (gray). Outlined are the most 
important non-conserved residues, in mAOH1 numbering. Also present is the XDH inhibitor oxipurinol molecule (OXI), 
and the conserved XDH and mAOH1 residues Phe919, Phe1014 and Glu1266. 
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Interestingly, the Tyr885 residue from mAOH1 is also not conserved in other aldehyde oxidases, 
particularly in human and mouse, where a methionine can be found. Mahro and co-workers 
(unpublished data) have expressed and purified the mAOH1 Y885M variant, from which we were 
also able to obtain protein crystals. The resulting crystals had poor or non-existing diffraction. 
Biochemically the authors found out that the variant shows the same behavior towards benzaldehyde, 
but that allopurinol (the most studied mammalian XOR inhibitor) which is a substrate for the wild 
type enzyme cannot be metabolized by the variant. Two different xanthine oxidase mutational 
changes (E803V and R881M, XDH numbering), were also reported a few years ago by Yamaguchi 
and co-workers [70]. Although these residues are not conserved in mAOH1, they are conserved in 
AO and the aim was to understand the role of some active site residues in binding and activation of 
purine substrates. As a result, the two variants showed significant aldehyde oxidase activity, which 
also indicates that it is the chemical nature of residues responsible for the different substrate binding, 
and not only its location within the protein active site. After the mutations, the overall active site was 
similar and no structural changes could be assigned.  
 
All the important mAOH1 residues (conserved and non-conserved), and their respective equivalents 
in bovine XDH are summarized in Table II. 4. 
 
On the basis of the above discussion it is clear that mAOH1 is different from XOR, predominantly in 
the catalytic active site, which indicates substantial differences around the MoCo substrate-binding 
site. As AO and XOR are characterized by distinct substrates and inhibitors, it is also predicted that 
the tunnel leading to the active site is different between the two enzymes. The existence of substrates 
recognized by mAOH1, but not by mAOH2 (E.Garattini, unpublished data), as well the identification 
of better inhibitors of mAOH1 than AO, further suggests that the tunnel may vary even among the 
different AO isoenzymes [16].  
 
Several residues along the funnel, which leads to the protein active site, are also not conserved 
between XDH and mAOH1 (Table II. 4). This explains the differences observed in the funnel shape 
and width, which is much wider and anionic in mAOH1 than in XDH (Figure II. 10). In mAOH1 the 
funnel leading to the active site is ~20Å wide at the surface and becomes tighter towards the 
molybdenum catalytic center, where it is approximately 8Å wide. This is consistent with the entrance 
of larger and bulkier substrates, as the ones described to be catalyzed by aldehyde oxidases.  
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Active Site 
 
Ala807* 
 
Glu802 
 
Tyr885* 
 
Arg880 
 
Lys889* 
 
His884 
 
Pro1015 
 
Thr1010 
 
Tyr1019 
 
Asn1014 
 
 
Funnel 
Arg717 Leu712 
Asp878 Leu873 
Glu880 His875 
Leu881 Ser876 
Thr1081 Pro1076 
 
Table II. 4 – Comparison between mAOH1 and bovine XDH, concerning the main residues involved in substrate 
binding and catalysis. Non-conserved residues marked with an asterisk are mentioned above, due to their primary 
importance. 
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Figure II. 10 - Surface view of the funnel leading to the active site in mAOH1 (left) and bovine XDH (right). The Mo 
atom is seen at the end of the funnel as a green sphere. The entrance is much wider in the case of aldehyde oxidase, with 
a narrow constriction closer to the molybdenum active site. Electrostatic surface potentials were calculated using the 
program delphy [71] and represented in PyMOL [72], with the color of surface potentials in the scale range from -0.10V 
(negatively charged, in red) to +0.10V (positively charged, in blue). 
 
2.3.5 The Reaction Mechanism 
The initially proposed reaction mechanism for XDH/XO forms described by Nishino and co-workers 
has been the origin of some debate and controversy over the years regarding binding mode and 
substrate orientation [13, 73]. However, a similar reaction mechanism as the one described for XOR 
has been also proposed for aldehyde oxidases [16]. With the reported mAOH1 structure (2.9Å), it is 
still not possible to identify the chemical nature of the atoms bound to molybdenum based on 
electron density maps. Therefore, in the absence of further evidence for the oxidized form of the 
enzyme and owing to the presence of highly conserved residues at the catalytic center (particularly 
Glu1266, in mAOH1 numbering), we assume that the reaction mechanism for aldehyde oxidase is 
similar to the xanthine oxidase mechanism. The reaction starts with the activation of the equatorial 
OH group by the neighboring conserved glutamic acid residue (Glu1266). This oxygen is then 
transferred to the substrate and the resulting intermediate replaces the coordinated OH at the 
molybdenum. Simultaneously, a hydride transfer from the substrate to the equatorial sulfur atom 
completes the reaction intermediate. The product is afterward released from the reduced 
molybdenum center and the new available position is occupied by a water molecule (Figure II. 11).  
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Figure II. 11 – Proposed reaction mechanism for aldehyde oxidase (AO). Represented is the base-assisted nucleophilic 
attack of the Mo-OH on the substrate carbonyl, with concomitant hydride transfer to the Mo=S. (Adapted from [16, 74]). 
 
The glutamate contribution to catalysis has been confirmed by site-directed mutagenesis in the 
recombinant mouse aldehyde oxidase (mAOX1). The E1265Q variant was generated and purified, 
and was unable to metabolize any of the aldehyde or purine substrate tested. This is consistent with 
an essential catalytic role for this residue [53]. The Glu1261 from XDH and the Glu1266 from 
mAOH1 are totally superimposable in the crystal structure (Table II. 4). To further investigate the 
aldehyde oxidase reaction mechanism in detail and draw comparisons with XOR, two different 
approaches must be taken. From the structural point of view, different crystal soaking experiments 
with substrates and inhibitors must be performed, as soon as crystal quality and resolution can be 
improved. Biochemical experimental data based on mutagenic studies should also be done in 
parallel. 
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3 CHAPTER 3  
Periplasmic Nitrate Reductase from Cupriavidus necator 
 
 
 
 
 
 
The work described in this chapter was the subject of two publications: 
 
C. Coelho, P.J. González, J.J.G. Moura, I. Moura, J. Trincão and M.J. Romão, (2011) “The crystal 
structure of Cupriavidus necator Nitrate Reductase in oxidized and partially reduced states” Journal 
of Molecular Biology, 408, 932-948; 
 
C. Coelho, P.J. González, J. Trincão, A.L. Carvalho, S. Najmudin, I. Moura, J.J.G. Moura, T. 
Hettman, S. Dieckman and M.J. Romão, (2007) “Heterodimeric nitrate reductase (NapAB) from 
Cupriavidus necator H16: purification, crystallization and preliminary X-ray analysis” Acta Cryst., 
F63,516-519.
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3.1 INTRODUCTION 
3.1.1 Cupriavidus necator 
Cupriavidus necator (Cn, formerly known as Ralstonia eutropha or Alcaligenes eutrophus), is a 
respiratory facultative "-proteobacterium. The Cn H16 strain is one of the best-studied model 
organisms for lithoautotrophic growth on molecular hydrogen and carbon dioxide, which are used as 
sole energy and carbon sources in the absence of organic substrates [75, 76]. Physiological and 
genetic studies revealed the presence of three different nitrate reductase activities in this strain [77]. 
The first activity corresponds to the cytoplasmic nitrate reductase protein (Nas), and was both 
repressed by ammonia and not sensitive to oxygen, suggesting a nitrate-assimilatory function. The 
second activity was only observed in the absence of oxygen and independent of ammonia 
suppression, representative of a nitrate respiratory function performed by the membrane bound 
nitrate reductase (Nar). The third activity occurred in the soluble fraction of cells, which were grown 
aerobically in the presence of ammonia during the stationary phase. This activity corresponds to the 
periplasmic nitrate reductase (Nap), whose expression, in contrast to Nas and Nar, did not require 
nitrate for induction. The genes for the three different nitrate reductases are mapped at different loci: 
Nas and Nar are chromosomally encoded, whereas Nap is located in a megaplasmid (pHG1) [27]. To 
elucidate the structure and function of C.necator periplasmic nitrate reductase, a homologous 
expression system was developed by Hettmann and collaborators [78]. A new C.necator strain 
(HF210) was used, together with the complete nap operon, and the protein was purified to near 
homogeneity. 
 
Several prokaryotic nitrate reductases from different organisms have been studied, and for some of 
them, the nap cluster has four genes in common: napDABC. The conservation of napA, napB and 
napC is expected, as they encode the terminal bis-MGD-containing moiety, the di-heme, and the 
tetra-heme components of the periplasmic electron transfer system respectively. The Tat (twin-
arginine transport) system is responsible for the translocation of folded proteins, across the 
cytoplasmatic membrane [79]. In E.coli, NapD is known to be a Tat signal peptide-binding 
chaperone involved in the biosynthesis of the Tat-dependent NapA.  After recognition of the twin 
arginine-containing motif in the signal sequences of the protein cofactor, insertion in NapA occurs in 
the cytoplasm, and the folded protein is then exported across the cytoplasmic membrane into the 
periplasmic compartment [27, 80].  
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3.1.2 Heterodimeric Periplasmic Nitrate Reductase (NapAB) 
Nitrate reductases depend on the bis-molybdopterin guanine dinucleotide (MGD) cofactor located in 
the active site, and belong to the DMSO reductase family of Mo proteins, described in section 1.1.6 
of this Thesis. The homologous expression of the periplasmic nitrate reductase from C.necator 
allowed biochemical and structural studies to be carried out, as well as elucidating its three 
dimensional architecture. Cn NapAB is a heterodimer composed of a large catalytic subunit (90 kDa) 
containing the molybdenum ion bound to two MGD cofactors plus a [4Fe-4S] cluster, and by a small 
di-heme c-type cytochrome subunit (17 kDa), involved in electron transfer. Different roles such as 
redox balancing and nitrate scavenging have been proposed for this protein. 
 
The first crystal structure for a nitrate reductase was solved by multiple-wavelength anomalous 
dispersion (MAD) in 1999 for the monomeric NapA from Desulfovibrio desulfuricans (Dd) at 1.9Å 
resolution [30]. In the following years, despite the extensive biochemical and spectroscopic 
characterization of several periplasmic nitrate reductases, few novel crystal structures were reported. 
In 2002, Brigé and co-workers published the structure of a proteolysed fragment of NapB subunit 
from Haemophilus influenzae (Hi) at atomic resolution (1.25Å), also with the help from MAD 
methods for deriving phase information [81]. One year later, the first crystal structure for a 
heterodimeric NapAB was obtained for the Rhodobacter sphaeroides (Rs) protein at 3.2Å resolution 
by Arnoux and collaborators [31]. The heterodimeric NapAB from E.coli was also studied in an 
attempt to determine its three dimensional structure, but due to heterodimer separation during 
purification protocols, the crystal structure could only be determined for the catalytic subunit at 2.5Å 
resolution [82]. In the oxidized form of these enzymes, the molybdenum atom is coordinated by two 
dithiolene ligands from the two MGD molecules, a S" atom from a Cys residue and a sixth ligand 
which was originally proposed to be a hydroxyl/water molecule. The sixth molybdenum ligand in the 
first crystal structure of NapA from D. desulfuricans was assigned as an OH/OH2 molecule (with 
Mo-O distance of approximately 2.1Å), but in recent studies obtained at higher resolution (1.8Å), 
and using improved refinement protocols, there was strong evidence that a heavier element (such as a 
non-protein sulfur ligand) is present at the sixth coordination position [33]. At the same time, crystals 
of the oxidized form of C.necator NapAB were obtained at high resolution (1.5Å) and the structure 
solved. The high resolution of the data provided atomic details of the protein active center and on 
molybdenum coordination sphere. The other Nap structures previously reported were solved to a 
resolution that was not enough to unequivocally identify the Mo ligands. The presence of sulfur as 
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the sixth molybdenum ligand implies that the formerly proposed reaction mechanisms simply based 
on the redox chemistry of Mo, could no longer be valid, and should also involve a sulfur-based redox 
mechanism. Three alternative reaction paths were proposed on the basis of the re-refined Dd NapA 
structure, and those have been the subject of theoretical and computational studies reported by 
different authors that provided similar results on the most favorable pathway of a putative 
mechanism [33, 83, 84]. 
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3.2 EXPERIMENTAL PROCEDURE 
3.2.1 Bacterial Expression and Growth Conditions 
Periplasmic nitrate reductase genes are not part of the Cupriavidus necator chromosome, but located 
in the 450 kb pHG1 megaplasmid. The protein was expressed in a megaplasmid-free strain (HF210) 
into which a broad host-range vector (pCM62) containing the complete Nap cluster was inserted 
[78]. The resulting strain was grown in mineral medium (Appendix – Table 1) at 30ºC until late 
death-phase [85]. The pre-culture was started by adding 20 .l of a C.necator (-pHG1-
H210/pNAP62-2 strain) glycerol stock solution into a nutrient broth agar plate and incubated 
overnight at 30ºC. Several colonies were afterwards chosen and resuspended, and again incubated 
overnight at 30ºC, 190 rpm. The resulting saturated cultures were used to inoculate 18 x 1L of 
mineral medium and incubated at 30ºC and 200 rpm until late death phase for almost 45 hours.  
 
This yielded enough protein for the initial robot crystallization trials (16 .l of 10 mg/ml NapAB), but 
not for the attempts to reproduce the robot conditions in-house. To overcome this problem, the 
bacteria were grown in a 10L pre-equilibrated reactor (BioStat B-Plus) inoculated with 200 ml of 
saturated cultures. The temperature was kept constant at 30ºC and the culture was continuously 
stirred between 200 and 400 rpm in order to maintain 20 % minimum oxygen level. After 49 h, the 
culture was centrifuged to isolate the periplasm. The protein obtained from the BioStat B-Plus 
reactor was used to scale-up the robot conditions, with the help from ionic liquids (Chapter 4), but 
was again insufficient to carry out the spectroscopic and electrochemical studies. To get such an 
enormous amount of protein, the bacteria were grown for the first time in a UD 300L Bioreactor at 
IBET (Oeiras, Portugal). To inoculate the industrial reactor, a pre-culture from a 10L ED 10 
Bioreactor grown at 30ºC for 24 h was used. All the conditions had to be optimized to such a large-
scale growth (Appendix - Table1). Temperature and pressure were kept constant at 30ºC and 100 
mbar, agitation varied between 100 rpm – 500 rpm in order to maintain 30% oxygen. Several 
aliquots were retrieved from the sample and immediate measurement of optical density at 600 nm 
was performed in order to monitor the growth rate. The fermentation was finished 48 hours after 
inoculation (Appendix – Figure 1). 
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3.2.2 Periplasm Isolation and Protein Purification 
For all the above growth experiments, periplasm had to be immediately isolated following the end of 
bacterial growth. In order to do this, the cultures were centrifuged at 5000g for 20 min and with a 
flow of 80L/h in a tubular centrifuge, respectively for the regular (10L) and industrial (300L) 
growths. The resulting pellets (16 g and 455 g respectively) were washed in 50 mM Tris-HCl pH 7.6 
and resuspended in 10 mM Tris-HCl pH 7.6 with 0.5 M sucrose (using 5 ml per gram of pellet). 
EDTA was added to a final concentration of 1 mM, and the cells were slowly agitated at 30ºC for 10 
min. Lysozyme was added to the sample (20 mg per gram of pellet) and the cells were vigorously 
stirred during 30 min at room temperature. The resulting suspension was centrifuged at 5000g for 20 
min and the supernatant which contained the periplasmic extract was clear, with a soft pink color 
very pronounced in the periplasm obtained from the cells grown in the 300L Bioreactor. 
 
The chromatographic purification protocol for the Nap protein comprised three main steps [86]. The 
sample was first dialyzed overnight against 10 mM MES pH 5.5 and loaded onto an S-Sepharose 
(GE-Amersham) column equilibrated with the same buffer. Cn NapAB was eluted between 200 and 
250 mM NaCl, and all the fractions containing the protein were pooled and concentrated by 
ultrafiltration in an Amicon system. The sample was afterward injected into a gel filtration Superdex 
200 column, equilibrated with 300 mM Tris-HCl pH 7.6. After buffer exchange by dialysis, the 
protein in 20 mM MES pH 5.5 was loaded onto a Mono-S (GE-Amersham) column and eluted with a 
NaCl gradient between 200 – 250 mM ionic strength. This final step was unnecessary in the 300L 
protein batch growth, possibly due to the higher amount of protein available. The protein was 
concentrated to 10 mg/ml (using the BCA procedure from Sigma) and stored in aliquots at -80ºC in 
10 mM Tris-HCl pH 7.6. 
 
3.2.3 Protein Crystallization and Data Collection 
Due to the initial limited amount of protein, the crystallization conditions were screened at the High 
Throughput Crystallization Laboratory in EMBL, Grenoble. The experiments were set up at 293K in 
a Cartesian PixSys 4200 crystallization robot (Genomic Solutions, UK) using the Index Screen from 
Hampton Research (96 conditions, Table 2-Appendix). Microcrystals were obtained under several 
conditions, using the sitting drop vapor diffusion method (Figure III. 1-a). The best crystals grew 
within one week to approximate dimensions of 0.13 x 0.09 x 0.04 mm3 using PEG 3350 as 
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precipitant, respectively at 25% (w/v) with 0.1 M bis-Tris propane pH 5.5; at 20%, with 0.2 M 
sodium formate pH 7.0, and at 15% with 0.1 M succinic acid pH 7.0 (conditions 42, 90 and 89). 
Equal volume of precipitant and protein solution (100 nl) were mixed and equilibrated over 90 .l 
reservoir solution. Crystals were flash-cooled directly in liquid nitrogen prior to transfer to a gaseous 
nitrogen stream (100K) using Paratone oil as a cryoprotectant. A 1.5Å high-resolution data set was 
obtained at beamline ID14-1 of the European Synchrotron Radiation Facility (ESRF - Grenoble, 
France) using an ADSC Quantum-4R CCD detector and a wavelength of 0.934Å (NATI dataset) for 
crystals from condition 42. They belong to space group C2, with unit cell parameters a = 142.2 Å, b 
= 82.4 Å, c = 96.8 Å, % = 100.7º and one NapAB heterodimer is present per asymmetric unit. 
 
 
Figure III. 1 - Crystals obtained using the crystallization robot at EMBL, Grenoble. (a) Microcrystals obtained for 
conditions number: 41, 65, 89, 82, 90, 43, 84, 93, 42 ,86, 47 and 71 from Hampton Index Screen (b) Enlargement of 
crystallization condition number 89; crystal dimensions 0.13 x 0.09 x 0.04 mm3. 
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Figure III. 2 - Diffraction pattern obtained at beamline ID14-1 (ESRF) for a NapAB crystal. Resolution at the edge is 
1.5Å. 
 
Several approaches were taken in order to reproduce the robot crystallization conditions in-house, 
including the use of water-soluble ionic liquids (IL) as additives (as explained in Chapter 4 of this 
Thesis). Another effective approach for crystallizing NapAB, after the 300L bacterial growth, was 
the streak seeding from a new robot plate setup using 25% PEG 3350 and 0.1 M bis-Tris pH 5.5 
(Hampton Research) in order to ensure reproducibility. This strategy also allowed growing suitable 
native crystals that diffracted beyond 1.7Å, which were used for soaking experiments. Statistics for 
data diffraction, processing and model refinement are presented in Table III. 1. 
 
The maximum resolution of the data was very much dependent not only on intrinsic crystal quality 
but also on crystal handling and cryo-cooling. For all conditions, several crystals had to be tested 
until a useful data set was obtained. These difficulties may explain the isolated case of one native 
crystal grown with the robot that diffracted to higher resolution (1.5Å). 
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Crystal sample 
(Approximate crystal size in mm) 
NATI 
Grown at HTX – EMBL 
(0.13 x 0.09 x 0.04) 
DIT-IL   (Grown with IL) 
Soak 20 mM Na dithionite 
(0.3 x 0.1 x 0.1) 
Beamline at ESRF ID14-1 ID14-2 
Wavelength (Å) 0.934 0.933 
Space group C2 C2 
Unit cell parameters (Å) a = 142.2, b = 82.4,  
c = 96.8, ! = 100.7º 
a = 119.4, b = 71.4,  
c = 128.4, ! = 121.0º 
Number of molecules in the AU 1 1 
Matthews coefficient (Å3/Da) 2.53 2.32 
Solvent content (%) 51.5 46.9 
Resolution limits  (Å) 43.23 - 1.50 28.34 - 1.72 
No. of observations 645330 363062 
No. of unique observations 170014 97895 
Multiplicity 3.8 (3.8) 3.7 (3.6) 
Completeness (%) 97.2 (95.2) 99.7 (99.1) 
Rmerge (%) 8.5 (53.7) 6.8 (17.7) 
I/$ (I) 8.5 (2.3) 16.8 (6.4) 
Resolution (Å) 37.90 - 1.50 27.63 - 1.72 
Nº reflections 170003 93004 
Rfree (%) 19.9 18.1 
Rfactor (%) 16.8 14.3 
Number of waters 670 787 
Number of other molecules - 19 formate ions 
1 chloride ion 
R.m.s. deviation from ideal geometry 
Bond lengths (Å) 
Bond angles (º) 
 
0.029 
2.324 
 
0.028 
2.31 
Average B factor for all atoms (Å2) 8.54 12.38 
Average B factor for waters (Å2) 16.31 21.67 
Ramachandran outliers (%) 0.67% 0.79% 
 
Table III. 1 - Statistics on data collection and structure refinement. Values in parenthesis correspond to the highest-
resolution shell. ¶ Rwork = 0 ||Fcalc| - |Fobs||/ 0 |Fobs| x 100, where Fcalc and Fobs are the calculated and observed structure 
factor amplitudes, respectively. (Rfree is calculated for a randomly chosen 5% of the reflections for each dataset). 
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3.2.4 NapAB Crystals and Soaking Experiments 
In order to clarify the Nap reaction mechanism, we have tried to obtain additional structural 
information on different forms of the enzyme. Crystals obtained either by seeding or with IL as 
additives were reproducible and used for soaking experiments with a harvesting solution containing a 
higher PEG 3350 concentration (30%). Crystals were incubated either with 20 mM potassium nitrate, 
10 and 20 mM sodium dithionite, or 20 mM potassium thyocianate (inhibitor of nitrate reductases). 
Incubations with mixtures of substrate/reducing agent as well as with hydrogen peroxide were also 
performed. More than 20 datasets were collected at ID14-1 and 2 at the ESRF at around 2Å 
resolution, which after refining revealed no major differences from the native form. After extensive 
attempts, one unique dataset could be collected from a crystal that diffracted to 1.7Å where changes 
were observed in comparison to the native structure (DIT-IL). This crystal was obtained using the 
ionic liquid (IL) [C4mim] Cl- (Chapter 4) and soaked with 20 mM sodium dithionite (DIT-IL 
dataset). Data-collection and processing statistics are presented in Table III. 1. 
 
Attempts were also made in order to crystallize Cn NapAB under controlled reducing conditions in 
an anaerobic chamber. The protein was introduced in the chamber and pre-incubated with 10 and 20 
mM sodium dithionite. Crystals were obtained at 293K for the same crystallization conditions and 
looked very similar to the ones obtained aerobically. However, initial attempts to flash-cool the 
crystals in liquid nitrogen inside the chamber to maintain reducing conditions were unsuccessful. The 
crystals were also retrieved from the chamber and frozen outside, but were destabilized and did not 
diffract. 
 
3.2.5 Processing 
Diffraction data for native (NATI) and dithionite-soaked crystals (DIT-IL) were collected at the 
ESRF, beamlines ID 14-1 and ID 14-2, respectively. Data were processed using MOSFLM v.6.2.5 
[59] and SCALA [87] from the CCP4 program package v.6.0 [88]. The calculated Matthews 
coefficients were 2.53 Å3Da-1 and 2.32 Å3Da-1, respectively, suggesting the presence of one NapAB 
heterodimer in the asymmetric unit for both crystal forms. The solvent content is 51.5% and 46.9% 
for NATI and DIT-IL data. Data-collection and processing statistics are presented in Table III. 1. 
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3.2.6 Structure Solution, Model Building and Refinement 
The C.necator NapAB structure was solved by molecular replacement, using the NATI dataset and 
the structure of the homologous enzyme NapA from D.desulfuricans (PDB accession code 2NAP) as 
a search model, with the program Phaser [63]. The complete NapA molecule was used, excluding the 
two MGD cofactors, the [4Fe-4S] cluster and the water molecules. The initial phases obtained by 
Phaser yielded a very good initial electron density map. These were used to run automated model 
building in ARP/wARP [89, 90]. The small NapB was positioned by superimposing the 
R.sphaeroides NapAB model (PDB accession code 1OGY) onto the solution, and using the NapB 
model as a starting point for rebuilding. After rigid body refinement, the overall model presented an 
Rfactor of 31.5% and an Rfree of 33.2%. Further model building was performed using COOT, and 
several refinement cycles of the experimental phases, using Refmac5 from the CCP4 program 
package v.6.0 were also done [62, 88]. After both chains were as complete as the density allowed, all 
cofactors were fitted into their respective electron density. Restrained refinement with TLS, using 
each of the four domains from NapA subunit treated as individual TLS entities, and three domains 
from the NapB subunit (total of 7 TLS groups), resulted in a final model with Rfactor and Rfree of 
16.8% and 19.9% respectively. Water molecules were automatically added with COOT.  
 
The 6th ligand of the Mo ion was initially omitted from the electron density map and a clear positive 
peak was obtained in an mFo-DFc map. This density was interpreted as either a hydroxyl/water 
molecule or as a sulfur ligand. When refined as oxygen, the difference between the relative B factors 
of the 6th ligand and the other Mo ligands was significant. This could be corrected when the 
refinement was carried out with a terminal sulfur ligand at the sixth coordination position. The same 
procedure used in the case of Dd Nap was followed [33]. No restraints were imposed on the sixth 
ligand for refinement. The B factor analysis is included in Table III. 2. 
 
The structure for the dithionite-soaked crystals (DIT-IL) was solved using the same procedure 
described for the native Cn NapAB. The native protein was used as model for molecular 
replacement. Water molecules were automatically added with COOT, electron density for formate 
molecules and one chloride ion was manually inspected and favorable contacts analyzed. The final 
Rfactor and Rfree for the DIT-IL structure were 14.3% and 18.1% respectively. No restrained 
refinement using TLS was used for this structure. Refinement statistics are presented in Table III. 1. 
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Dataset 
 
NATI 
 
DIT-IL 
Dd NapA[30] 
(PDB: 2NAP)  
 
EcNapA* [82] 
(PDB: 2NYA) 
 
Wilson B-factor  (Å2) 11.6 11.4 39.55 - 
S1 MetA346 6.71 6.07 28.1 21.2/21.0 
S12 MGD1803 10.45 5.56 32.2 20.2/21.4 
S13 MGD1803 9.19 5.76 28.1 19.2/22.3 
S12 MGD1804 9.43 6.03 25.2 21.1/24.4 
S13 MGD1804 9.23 5.37 29.8 13.3/21.4 
S1 MetA153 7.99 7.69 30.0 20.2/25.6 
S" CysA152 9.64 4.20  33.6 20.2/25.6 
Mo 9.60 5.96 29.6 20.3/24.4 
S900   13.24 8.91 25.3 - 
HOH (at S900 position) 2.0 2.0 7.51 5.86/2.0 
*The first value is for molecule A, the second for molecule F in 2NYA 
Table III. 2 - The Mo active site and B factor analysis.   
 
After some refinement steps of the DIT-IL structure using COOT and Refmac5, unmodeled positive 
electron density (>4)) was also found next to the sulfur atom of Cys784. The three clear blobs were 
interpreted as a modified cysteine sulfonic acid (OCS) and included in the final model. While water 
molecules were automatically added with COOT, electron density for formate molecules and one 
chloride ion was manually inspected and favorable contacts analyzed. The final Rfactor and Rfree for 
the DIT-IL structure were 14.3% and 18.1% respectively. No restrained refinement using TLS was 
used for this structure. The two final models included the following amino acid residues: For NATI, 
Val4-Val802 for the NapA subunit and Gly1-Lys124 for the NapB subunit; for DIT-IL, Lys11-
Val802 for NapA and Gly1-Leu123 for NapB. In both models, the di-heme NapB subunit has two 
short regions with no visible electron density: residues Lys27-Met37 and Thr65-Ala72. Refinement 
statistics are presented in Table III. 1. 
 
Coordinates and structure factors from both structures have been deposited in the Protein Data Bank, 
with the accession codes 3ML1 (NATI) and 3O5A (DIT-IL). 
 
3.2.7 EPR Spectroscopy 
In order to study the EPR properties of C.necator NapAB, continuous wave (CW) X-band spectra 
were recorded with a Bruker EMX spectrometer (model ER4116DM) equipped with a dual-mode 
cavity and an Oxford Instruments continuous flow cryostat. Simulations were performed using the 
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WIN-EPR Simfonia V1.2 software from Bruker Instruments. EPR samples were prepared in 100 
mM HEPES pH 7.0, with a NapAB concentration of 200 .M (# 21 mg/ml). All spectra were 
obtained in nonsaturating conditions: microwave power, 0.6 mW; modulation amplitude, 5 Gpp; 
modulation frequency, 100 kHz. Spin quantification of the Mo(V) and FeS signals were estimated by 
double integration and comparison with Cu-EDTA standards. 
 
3.2.8 Spectropotentiometric Redox Titrations 
UV-Vis and EPR mediated redox titrations were carried out in an anaerobic chamber at room 
temperature and oxygen concentration below 1 ppm. A platinum–silver/silver chloride combined 
electrode (Crison), calibrated with a saturated quinhydrone solution at pH 7.0 was used to determine 
the electrochemical potential of the solution.  
 
For UV-Vis, a total assay volume of 3.0 ml contained 100 mM HEPES pH 7.0 buffer and final 
protein concentration was ca. 3 mg/ml. Mediators, at 5 µM each, were: methyl viologen (-440 mV), 
neutral red (-325 mV), anthroquinone (-225 mV), fenazine (-125 mV), indigo tetrasulfonic acid (-46 
mV), duroquinone (5 mV), galocyanine (30 mV), fenazine etasulfate (55 mV), fenazine metasulfate 
(80 mV), 2,5-dimethyl benzoquinone (180 mV), and 2,6-dichlorophenolindophenol (217 mV). 
Sodium dithionite and potassium ferricyanide solutions were used as reducing and oxidant agents, 
respectively. Optical data were collected using a TIDAS diode array spectrophotometer. 
 
For EPR, the protein solution was incubated with the following mediator dyes, at 10 .M: benzyl 
viologen (-340 mV), di-hydroxy 1,4-naphtoquinone (-145 mV), indigo disulfate (-125 mV), resorufin 
(-51 mV), methylene blue (11 mV), phenazine metasulfate (80 mV), 1,2-naphtoquinone (180 mV), 
and 1,2-naphtoquinone sulfonic acid (217 mV). The electrochemical potential was dropped using a 
potassium ascorbate and sodium dithionite solution, dissolved in 100 mM HEPES pH 7.0. Samples 
for EPR spectroscopy (100 .l) were taken after equilibration at each potential and frozen in liquid 
nitrogen. Values of redox potentials are expressed relative to the standard hydrogen electrode (SHE). 
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3.2.9 Electrochemistry 
Voltammetric measurements were performed using an Autolab PSGTAT10 potentiostat /galvanostat 
from ECO Chemie (Utrecht, The Netherlands). The system was controlled and data analyzed with 
the GPES software package from ECO Chemie. Scan rate varied between 5 and 50 mVs-1. A three 
electrode configuration cell was utilized, with a platinum auxiliary electrode, and an Ag/AgCl 
reference electrode (205 mV vs standard hydrogen electrode, SHE). As working electrodes, graphite 
and gold disks were used. The latter was from BAS (MF-2014) with a nominal radius of 0.8 mm. As 
to the graphite electrodes, a homemade pyrolytic graphite (PGEh) and a commercial ultra-trace 
graphite (UTGEh) (Metrohm, ref. 6.1204.100) both with nominal radius of 0.1 mm, were used. 
Before each experiment the electrodes were polished by hand on a polishing cloth (Buehler 40-7212) 
using water/alumina (0.3 .m) slurry (Buehler 40-6365-006), sonicated for 1 min and then well rinsed 
with Milli-Q water. In most experiments with the graphite electrodes, a 2 µl drop of a mixture (1:1) 
of 93 .M NapAB (10 mg/ml) and 20 mM Neomycin, was deposited on the electrode surface and left 
to dry at room temperature for 30 min. In other experiments, a membrane electrode configuration 
was prepared (either graphite or gold) using a negatively charged Spectra/Por MWCO 3500 
membrane. 
 
The supporting electrolyte contained 10 mM Tris-HCl pH 7.6 and 0.1 M NaCl. In potassium nitrate 
assays, the final concentration in the electrolyte solution varied between 10 .M and 10 mM.  In the 
experiments with hydrogen peroxide, final concentration varied between 50 .M and 500 .M. 
Oxygen was removed by the action of a nitrogen stream for 20 min. Nitrogen continued to flow on 
the top of the solution during all experiments in order to maintain anaerobic conditions. All 
measurements were performed at least in duplicate in a temperature-controlled room at 20 ± 1 ºC. All 
potential values are referred to the standard hydrogen electrode SHE. 
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3.3 RESULTS AND DISCUSSION 
3.3.1 Overall Structure Description 
The periplasmic nitrate reductase from Cupriavidus necator is a heterodimer (NapAB). The large 
catalytic subunit (NapA) comprises 802 amino acid residues and contains the Mo ion, bound to two 
MGD cofactors and a [4Fe-4S] cluster. The small subunit (NapB) is 134 residues long and harbors 
two low-spin c-type hemes, with two histidines as axial ligands (Figure III. 3). One of the histidine 
residues is preceded by a second Cys in the canonical CXXCH binding motif. NapB is responsible 
for transferring electrons from the physiological partner to NapA, where nitrate is reduced to nitrite. 
During purification and crystallization, the two subunits remained tightly bound, providing the 
complete heterodimeric form of the protein. This was also reported for the heterodimeric nitrate 
reductase from R.sphaeroides. Dissociation of the two subunits was observed in the E.coli NapAB in 
which case NapA and NapB have been purified independently [26, 31, 82]. 
 
The overall topology of the C.necator catalytic chain is very similar to the monomeric NapA from 
D.desulfuricans, with the exception of two loops (residues 267-297 and 543-596) that protrude from 
the globular structure in the Cn NapA structure. The overall globular shape of Cn NapAB has 
approximate dimensions of 65Å x 65Å x 58Å. The catalytic core is deeply buried in the protein with 
a substrate channel of ~15Å leading to it. The channel is oriented opposite to the heterodimer contact 
interface. The distance from Mo to the nearest Fe atom of the [4Fe-4S] cluster is 12Å, with a 
conserved Lys (K56) mediating electron transfer between the two cofactors. Cn NapA is divided into 
four main domains classified as defined for Dd NapA (Figure III. 3). The catalytic subunit NapA 
overall fold is formed by discontinuous stretches of the polypeptide chain. The N-terminal domain I 
(red) is composed of three segments (residues 4-68, 507-531 and 600-641) and contains the four Cys 
residues (Cys19, 22, 26 and 54) that coordinate the [4Fe-4S] center. Domains II and III share an 
overall $/%-fold very similar to each other (represented in green and yellow respectively), and each 
one harbors a MGD cofactor. Domain II is also composed by three non-contiguous chains of residues 
(69-148, 386-506 and 532-599) while domain III comprises residues 149-385. The C-terminal 
domain IV (blue) presents a typical %-barrel fold and is very solvent exposed (residues 642-802) 
[30]. 
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Figure III. 3 - A) Crystal structure of the C.necator NapAB (ribbon representation) showing the domains colored as 
follows: domain I in red (residues 4-68, 507-531 and 600-641); domain II in green (residues 69-148, 386-506 and 532-
599); domain III in yellow (residues 149-385); and domain IV in blue (residues 642-802). The Mo-bis-MGD cofactor is 
shown in sticks and colored by atom type, and the [4Fe-4S] as orange sticks. NapB is represented in grey ribbon and the 
2 hemes as sticks colored by atom type. B) Arrangement of the metal cofactors: Mo (MGD)2, [4Fe-4S] and di-heme c-
type cytochrome color-coded as atom types. Included are also two strictly conserved residues from NapA: Lys56A that 
mediates the contact between the pterin and the [4Fe-4S] cluster as well as Tyr58A, involved in intersubunit electron 
transfer between the [4Fe-4S] center and heme I. 
 
The NapB subunit is characterized by a low structural complexity. The polypeptide chain has a 
spread-out shape with extended N- and C-terminal segments and a small globular domain in the 
middle (Figure III. 3 and Figure III. 4). The last 10 residues, as well as two solvent exposed regions 
of Cn NapB had no visible electron density (residues 28-36 and 66-71). The globular domain has 
approximate dimensions of 30Å x 20Å x 20Å and is composed of three short $-helices (Arg57-
His62, Ile77-His79 and Cys98-Cys101) linked by large loops. The long N-terminus extended region 
(first 27 residues as random coil) in addition to the extended C-terminus (residues 103 to 124 that 
include a short $-helix, Val119-Leu124) resemble two arms that embrace NapA, spreading from 
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domain II all the way around domain IV. The stabilization of the NapAB complex is dominated by 
hydrogen bonds and salt bridges, involving mainly residues from both arms (Figure III. 4). The two 
c-type hemes in NapB are almost parallel to each other, in a stacked position with an iron-to-iron 
distance of 10.0Å, and at 14.7Å distance between the heme II iron atom, and the nearest iron from 
the [4Fe-4S] center. The side chain of Tyr58 from NapA lies between both centers at the intersubunit 
interface. Its hydroxyl group is 7.9Å and 7.6Å away from the nearest atom of the Fe/S cluster, and 
from the Fe atom of heme II, respectively (Figure III. 3). This tyrosine is conserved in all 
heterodimeric nitrate reductases but not in the monomeric Dd NapA, where is replaced by a serine 
residue. In the crystal structures of the heterodimeric nitrate reductases (Cn NapAB, Rs NapAB and 
Ec NapA(B)) Tyr58 adopts the same orientation, strongly suggesting its role in mediating electron 
transfer between NapA and NapB.  
 
The propionate side chains from both hemes are oriented towards the solvent. The stacked 
arrangement of both hemes, within van der Waals contact distances, is unusual and resembles the 
heme arrangement first reported for the split-Soret cytochrome c (SSC) from D.desulfuricans ATCC 
27774 [91]. However, there is no relationship between the fold of Dd SSC and NapB. The amino 
acid sequence of the NapB cytochrome shows two typical CXXCH motifs (Figure III. 5), with the N-
terminal heme-binding site located nearly halfway along the protein sequence. The Fe atom of each 
heme is coordinated by two strictly conserved axial histidine residues (His44B and His62B for heme 
I, and His79B and His102B for heme II) (Figure III. 5). No significant sequence homology to other 
c-type cytochromes was found. Based on this, and on its particular structural features, NapB can be 
considered as representing an unusual class of c-type cytochromes with short Fe-Fe distance and 
parallel arrangement of the hemes located on one side of the protein. The structural features of c-type 
cytochrome NapB as well as its orientation in relation to NapA may favor intermolecular electron 
transfer between NapA, NapB and NapC. 
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Figure III. 4 - Superposition of the NapB subunit from C.necator (red) with NapB from R.sphaeroides (green) and the 
segment of residues 38 to 105 from H.influenzae (blue). The Cn NapA is represented as a gray surface. 
 
3.3.2 The NapAB Heterodimer 
In C.necator, the catalytic subunit NapA is tightly bound to the subunit NapB, with a total buried 
surface area of 6005Å2. This interaction involves several hydrogen bonds and salt bridges. The 
majority of these bonds are established by residues mostly from NapA domains I, III and IV, that 
interact with residues from NapB. From a total of 24 hydrogen bonds (< 3.2Å) and 4 salt bridges 
between NapB and NapA residues, only 5 involve residues from the core domain of NapB. The other 
19 involve residues from the extended N-arm (Asp4B, Met6B, Arg7B, Asn14B, Glu15B, Ala18B, 
Pro19B and Glu25B) and C-arm (Gln105B, Ala106B, Thr108B, Gly113B, Asn114B and Asn115B) 
of NapB. The 4 salt bridges that mediate the complex interface involve residues Asp4B, Glu15B, 
Glu25B and Arg83B. The majority of the conserved residues in the NapB proteins are located in the 
proximity of the two heme groups in the small globular domain (residues 27 to 103) (Figure III. 5). 
The less conserved regions correspond to the two long arms and the differences may explain why in 
some organisms, such as E.coli or H.influenzae, dissociation between NapA and NapB occurs. 
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Figure III. 5 - a) Comparison of the amino acid sequence of NapA from C.necator with the other nitrate reductase 
catalytic subunits of know structures (R.sphaeroides, E.coli and D.desulfuricans). The [4Fe-4S] binding Cys residues are 
marked as (!) and the Mo ligand Cys152 as (*). b) Comparison of the amino acid sequence homology of NapB from 
C.necator, R.sphaeroides, H.influenzae and E.coli. Binding residues (H----CXXCH) for heme I are marked as (2) and for 
heme II as (3). Black boxes indicate identical residues, and grey indicate similar ones. Alignment results obtained with 
CLUSTALW multiple sequence alignment program at the EMBL-EBI web server, and the figure prepared using 
BOXSHADE from EMBnet server. 
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3.3.3 Comparison with Homologous Crystal Structures 
Several crystal structures of periplasmic nitrate reductases have been reported in the past few years. 
As mentioned before, the first was the monomeric NapA from D.desulfuricans at 1.9Å [30], while 
the NapAB from R.sphaeroides was the first structure of a heterodimeric Nap protein [31]. Crystal 
structures of the individual subunit NapA from E.coli [82], as well as of a proteolysed fragment of 
H.influenzae NapB were also reported, the later corresponding to a globular domain of Hi NapB [81] 
obtained by proteolysis of recombinant protein (a 8.5 kDa fragment, instead of the complete 15 kDa 
subunit). 
 
Comparing the two heterodimeric NapAB crystal structures (C.necator and R.sphaeroides) we can 
see that both proteins share a similar overall globular shape, folding and cofactor localization. The 
buried surface area as well as the number and type of intersubunit contacts found in both complexes 
are also very similar. The Cn NapA and Rs NapA subunits share 71% sequence identity and the same 
number of amino acid residues (802). Both structures superimpose with an rms deviation of 0.67Å 
for 780 C$ atoms. The monomeric NapA from D.desulfuricans shares only 36% sequence identity 
with Cn NapA but the two structures are also quite similar (rmsd of 0.9Å over 590 C$ 
superimposed). Structural comparisons with E.coli NapA also revealed no major differences. Both 
share 69% sequence identity with an rmsd of 0.51Å for 781 superimposed C$ positions. The main 
differences among all four NapA structures are the two exposed loops conserved in Cn, Rs and Ec 
NapA but absent in the Dd NapA structure (residues 267-297 and 543-596, Cn NapA numbering). 
 
In contrast to the catalytic subunit Cn NapA, the electron transfer subunit Cn NapB has a lower 
sequence identity (52%) with R.sphaeroides NapB and the two structures superimpose with an rmsd 
of 0.96Å (86 superimposed out of 134 C$ atoms). The structure of the Hi NapB proteolysed 
fragment superimposes onto Cn NapB with an rmsd of 0.78Å for 49 C$ atoms. These two proteins 
share only 37% sequence identity. The core domain of the three NapB structures is very similar with 
the exception of a short $-helix present in the Hi NapB (residues 65-72) (Figure III. 4). This 
corresponds to an exposed polypeptide that appears disordered in the Cn NapB structure (residues 
Arg66- Gln71) showing no continuous electron density. In Rs NapB this same region is unstructured 
and protrudes towards the solvent. 
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Comparing the electrostatic surface potential for the different enzymes, we can see that around the 
solvent exposed funnel (Figure III. 6-A) Cn NapAB is markedly positively charged, and similar to 
the surfaces of NapA from E.coli and from D.desulfuricans. In the case of the R. sphaeroides 
protein, the electrostatic surface potential is clearly more anionic. The similarity between the Cn 
NapA, Ec NapA and Dd NapA funnel surfaces may be explained by common evolution of the 
proteins in the different bacteria, possibly due to evolutionary conditions of adaptation, while the Rs 
NapA could have a distinct evolution. The electrostatic contact surface between NapA and NapB 
(Figure III. 6-B) is quite similar in both Cn and Rs heterodimeric proteins. The corresponding surface 
on Ec NapA at the NapB binding interface is apparently more positive than for Cn and Ec NapA. In 
spite of the observed differences, there is no clear pattern and it is hard to draw conclusions simply 
on the basis of the surface electrostatic potentials, regarding the stability of the NapAB complex, 
namely the lower dimerization affinity in Ec NapAB. 
 
 
 
Figure III. 6 - Electrostatic potentials of Nap structures surfaces. Electrostatic surface potentials were calculated using 
the program delphy [71] and represented in PyMOL [72], with the color of surface potentials in the scale range from -
0.10 V (negatively charged, in red) to +0.10 V (positively charged, in blue). A) View towards the substrate tunnel leading 
to the active site of Cn NapAB, Rs NapAB, Dd NapA and Ec NapA; B) NapA surface interaction with the small subunit 
NapB, from Cn, Rs and Ec (NapB from Cn), all in the same orientation. 
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Amino acid sequence alignment for the four NapB subunits (Figure III. 5-B) shows that the core 
globular domain sequence that binds the two hemes (residues 34 to 106), is highly conserved. In 
contrast, the N- and C-terminal arms differ in their primary structures, although these are the regions 
of NapB that mostly contribute to the complex stabilization. Most of the residues from NapA that 
form the dimer interface are from segments 47A to 67A and 706A to 777A, and are involved in 
hydrogen bonding interactions (direct or water mediated) and salt bridges. It is interesting to note 
that from these interface residues, some are conserved only in the proteins that purify as dimers (Cn 
and Rs) and not in Ec and Dd NapA: Glu47, Tyr712, Glu737, Arg748, Arg750, Arg750 and Ser772 
(all from subunit A). In a recent study of NapA from Shewanella gelidimarina, the authors proposed 
that only two of those residues (Glu47 and Ser772 using Cn numbering) should be crucial for the 
heterodimer stabilization [92]. However, when analyzing the structure interfaces of Cn NapAB and 
of Rs NapAB it appears more likely that the stability of the NapAB heterodimer, and therefore the 
preservation of its integrity upon purification, is due to a combination of multiple intersubunit 
interactions. Analyzing for the presence of some of these residues might help to predict whether a 
certain Nap protein is expected to isolate as a NapA monomer or as a NapAB heterodimer. 
 
3.3.4 The Molybdenum Catalytic Site 
The NapA active site is accessible from the solvent area, through a funnel-shaped cavity defined by 
residues from domains II and III (Figure III. 7). The entrance from the wider part of the funnel is 
coated with highly conserved and charged residues (Arg392, 400 and 150, Asp167 and Glu168). 
Arg392 and Asp167 form a salt bridge and are directed towards the active site, while Glu168 is a 
Ramachandran outlier in all Nap structures. Asp167 and Glu168 are located in an exposed loop at the 
mouth of the funnel. Mutation of Asp167 to Ala (in single and double mutants, D167A and D167A-
E168G, respectively) leads to total loss of nitrate reductase activity [93]. These observations suggest 
that the positioning of those conserved residues and the charged patch are essential for anchoring and 
orienting the substrate towards the Mo active site or are important for protein maturation and/or 
cofactor insertion [6, 94]. The NapA funnel cavity is lined with several ordered water molecules. In 
the DIT-IL structure, where formate is present in the crystallization buffer, three formate ions were 
found at mid height of the funnel. A total of 19 formate ions were modeled, with all other present on 
the solvent exposed surface of the heterodimer. The formate molecule (Fmt1) closest to the active 
site (13Å from the Mo) contacts the guanidinium group of Arg400. Fmt5 contacts Arg150, and Fmt7 
is stabilized through H-bonding interactions with Asp167, Glu168 and His616 (Figure III. 7). 
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Figure III. 7 – Stereo view of the substrate funnel with 3 formate ions and conserved charged residues involved in 
orienting the substrate into the Mo active site (DIT-IL structure). 
 
The molybdenum active site is found at the bottom of the solvent accessible funnel and in the native 
oxidized form, the Mo atom is coordinated by six sulfur ligands: four provided by the two dithiolene 
ligands (MGD1803 and MGD1804), one from the S" atom of Cys152, and a sixth terminal sulfur 
ligand. Although in the original Dd NapA structure the sixth ligand was assigned as an OH ligand 
[30]), recent studies on the same enzyme reacted with reducing agents, substrates and inhibitors, 
provided new evidence on molybdenum active site details, allowing to assess the sixth Mo ligand as 
a sulfur atom [33]. The structure of the NapAB from C.necator here described constitutes the first 
true atomic resolution structure of a nitrate reductase. A similar analysis for Cn NapAB with 1.5Å 
data (as performed for Dd NapA, [33]) confirmed the true nature of the molybdenum coordination 
sphere (Table III. 2). When refining the 6th Mo ligand as oxygen, positive electron density was 
obtained on a difference density map, which completely disappeared when assigning it a sulfur atom 
(Figure III. 8-A and Figure III. 8-B). Besides, the B-factor of an oxygen atom at this position is lower 
than 2 Å2, well below the average B-factor of the surrounding atoms (~9Å2). When considered as a 
sulfur atom, its B-factor refines to 11Å2 (Table III. 2). As in the Dd NapA structure, the two sulfur 
atoms form a partial disulfide bond (S--S, 2.55Å) (Figure III. 8-C). A unique coordination sphere of 
six sulfur ligands bound to molybdenum suggests that this is most likely a general feature for all 
periplasmic nitrate reductases. 
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Figure III. 8 - Close-up of the Mo coordination sphere for the native (A and B) and dithionite-reduced forms (C).  The 
2mFo-DFc electron density maps are contoured at 1) (blue) and the mFo-DFc map at 3) (red). A) Refining the sixth Mo 
ligand as an oxygen atom yielded positive electron density on an mFo-DFc map. This density completely disappeared 
when assigning it as a sulfur atom (B). C) In the partially dithionite-reduced form (DIT-IL) there is extra positive density 
at the C% atom of Cys152 that could be modeled as two alternate conformations with 88% and 12% occupancies. 
 
3.3.5 The Catalytic Site in Dithionite Reacted Crystals 
To further clarify Nap reaction mechanism, it was important to have additional structural information 
on the reduced form of the enzyme. Several strategies to prepare crystals of the reduced form of Cn 
NapAB by soaking reducing agents into previously obtained crystals were used. However, the 
majority of the reacted crystals was damaged and did not diffract at all or only to poor resolution. On 
the other hand, some dithionite treated crystals that did diffract revealed no significant changes at the 
active site. After extensive attempts, one unique dataset could finally be collected from a crystal that 
diffracted to 1.7Å. This crystal was obtained using the ionic liquid (IL) [C4mim] Cl-, and soaked with 
20 mM sodium dithionite (DIT-IL). Data analysis revealed interesting changes in the vicinity of the 
molybdenum active site. Of particular relevance was the presence of extra positive electron density 
close to the C%  of the coordinating Cys152, which suggested a possible movement of the 
corresponding side chain. Towards the end of the refinement, these modifications at the active site 
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were interpreted as two alternate conformations of Cys152, with 0.88 and 0.12 occupancies. In the 
final DIT-IL model all atoms for both conformations had B-factors within the same range as the 
surrounding atoms. Figure III. 8-C represents the final coordination geometry for the two 
conformers. However, due to the low occupancy (12%) of the displaced Cys conformation, one 
should be cautious when analyzing the corresponding bond distances. At this level of occupancy the 
uncertainty of the atomic positions is too large and one cannot claim if this conformation 
corresponds to an unbound form or not, although the shape of the electron density may suggest it. 
 
3.3.6 Reaction Mechanism 
The new coordination sphere of molybdenum, with a total of six sulfur ligands and no oxygen 
directly bound to the metal, was first revealed by the reanalysis of the Dd NapA crystal structure and 
confirmed with the Cn NapAB structure here described. In both active site structures, the sulfur atom 
from the coordinating Cys is making a partial disulfide bond with the terminal sulfido ligand (Figure 
III. 8-C). The new nitrate reductase active site definition required a revision of the reaction 
mechanism. Three alternatives were proposed, considering that substrate binding and reaction 
pathway must combine molybdenum and sulfur redox chemistry [33]. Two of the possible 
mechanisms involve direct binding of nitrate to the Mo atom (first coordination sphere) while the 
third one involves binding of nitrate to the terminal sulfur ligand, in the second coordination sphere 
of the metal. Subsequently, theoretical and computational studies were performed by different 
authors in order to investigate which of the alternative paths was energetically more favored [83, 84, 
105]. Interestingly they all came to the same conclusion that the most viable mechanism should 
involve a direct binding of nitrate to the Mo atom. In order to open free access to the metal center, 
the Cys ligand must disconnect from Mo, but remain bound to the sulfur ligand (fragment Mo-S-S" 
Cys).   
 
The alternate conformation of Cys152 found in the Cn NapAB structure of the partially reduced form 
here reported, reflects the redox interplay between Mo and the sulfur ligands, supporting a reaction 
mechanism, which involves rearrangement of the Cys152 coordinating position. 
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3.3.7 The Presence of Oxidized Cysteines 
As previously mentioned, during final refinement steps of the DIT-IL data, three positive electron 
density blobs were clearly visible (> 4)), near the sulfur atom of Cys784, close to the substrate 
funnel. This density was modeled as three oxygen atoms of cysteine sulfonic acid (-CH2SO3H). After 
refining this modified Cys784, B-factors for the three oxygen atoms were within the range of the 
surrounding atoms. In addition, Cys388 also revealed extra positive electron density but not as clear 
as for Cys784, and therefore it was left unmodified in the deposited model. The presence of oxidized 
cysteine residues was totally unexpected and was observed only in the data from Cn NapAB crystals 
treated with sodium dithionite (DIT-IL). The oxidation of cysteine residues has been reported in the 
literature as the result of peroxidation, and has been also related with the important role of cysteines 
as redox-sensitive regulatory switches [94, 98, 99]. As the soak experiments were performed in the 
presence of O2, there is a possibility that the free-thiol group of cysteines had reacted with hydrogen 
peroxide resulting from the reaction reduction of O2 by dithionite (according to the reaction: 
Na2S2O4+O2+2H2O ! 2NaHSO3 +H2O2). Although dithionite can also react with the formed 
peroxide, this reaction is much slower and H2O2 may accumulate in solution [100]. In order to test 
this hypothesis, native Cn NapAB crystals were treated with a hydrogen peroxide solution and 
datasets were collected (data not deposited). As expected, similar results were obtained for this 
crystals and clear electron density revealed the cysteine Cys784 oxidation (and of Cys388 to lower 
extent). It is important to note that in these peroxide soaked crystals no changes were observed in the 
active site, in particular at the Mo ligand Cys152. Both cysteine residues are solvent accessible, and 
located at (Cys388) or close (Cys784) to the substrate channel, although only Cys388 is strictly 
conserved among periplasmic nitrate reductases. The presence of oxidized cysteines in Cn NapAB is 
most probably irrelevant from the functionality point of view. Nevertheless, care must be taken when 
interpreting structural data where dithionite has been used as a reducing agent, as is often the case in 
crystal structures of reduced forms of metalloproteins [101, 102]. 
 
3.3.8 Spectroscopic Characterization 
The UV-visible spectrum of Cn NapAB exhibits typical features of a heme protein, with a Soret band 
centered at 409 nm (4= 200,000 M-1cm-1) and a protein band at 275 nm (4 = 240,000 M-1cm-1). The 
characteristic absorption features of the iron-sulfur cluster, usually found around 350-500 nm, are 
covered by the heme absorption bands and cannot be observed. Upon ascorbate or dithionite addition 
in anaerobic atmosphere, the Soret band shifts to 419 nm (4 = 280,000 M-1cm-1) and ! and " bands 
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can be observed at 550 nm (4 = 66,000 M-1cm-1) and 522 nm (4 = 41,000 M-1cm-1), respectively. The 
latter features are characteristic of c-type hemes with ferrous ion in a low electronic spin 
configuration. A UV-visible mediated redox titration in the +300 to -400 mV range, revealed that 
changes in the 550 nm absorption band can be observed in the range of +200 to 0 mV. Similar to 
what was observed for other periplasmic nitrate reductases, these changes are bi-phasic and can be 
fitted with a Nernstian curve of two independent hemes with n=1 and Em values of +50 mV and +160 
mV (Figure III. 9). As the Cn NapAB complex is very tight, it was impossible to dissociate both 
subunits to study their redox properties separately, as performed in Nap from R.sphaeroides and 
from E.coli [31, 82].  
 
 
Figure III. 9 - A) UV-Vis mediated potentiometric redox titration of the c-type hemes present in C.necator periplasmic 
nitrate reductase. The absorbance at 553 nm was normalized and plotted versus the redox potential of the solution E (at 
pH 7.00). Experimental data (circles) were fitted with a nonlinear regression (grey line) using the Nernst equation for two 
independent components with Em values of 160±5 mV and 50±2 mV (errors from oxidative and reductive titrations). B) 
EPR spectropotentiometric redox titration of the [4Fe-4S] cluster present in the large subunit of Cn NapAB. The area of 
the FeS EPR signal was normalized and plotted versus the redox potential of the solution E (at pH 7.00). Experimental 
data (circles) were fitted with a nonlinear regression (gray line) using the Nernst equation for one electron with an Em 
value of -15 mV. 
 
The midpoint redox potentials of the hemes of the Cn NapAB heterodimer, and those of other Nap 
proteins are reported in Table III. 3. The values obtained for Cn NapAB are higher (mainly for heme 
I) and in the positive limit of the redox potential range expected for c-type cytochromes with a bis-
histidinyl coordinated heme (-350 mV to +150mV) [104]. At present, there is no established 
correlation between the redox potential of a heme and the factors that tune such value, and no 
unusual features can be observed in the crystal structure. The continuous-wave X-band electron 
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paramagnetic resonance (EPR) spectrum of air-oxidized Cn NapAB recorded at 15 K (Figure III. 10) 
contains a low spin (S = 5) rhombic species with g-values of 2.935 (90 G), 2.275 (100 G) and 1.487 
(400 G) (line widths in parentheses). A feature at g~2 arising from a fraction (0.02-0.05 
spin/molecule) of the Mo ion present in the paramagnetic Mo (V) state (S=5) is also visible. The 
spin integration of the rhombic signal yields near 2 spin per NapAB heterodimer, indicating that both 
hemes contribute to this EPR signal. The g-values used for spectrum simulation yield crystal field 
parameters //&= 2.93 and V// = 0.63, which are characteristic of low spin hemes with bis-His 
coordination, in which the planes of the imidazole rings from the histidines are nearly parallel [103]. 
This is in agreement with the X-ray structure obtained for the oxidized crystal form.  
 
Sample 
 
heme I heme II [4Fe-4S] Reference 
Cn NapAB 
 
+50 +160 -15 This work 
Ec NapAB (NapA) 
 
-160 +10 -250 (+20) Jepson et al, 2007 [82] 
Rs NapAB (NapA or B) 
 
-210 -65 (-110) -70 (-250) Arnoux et al, 2003 [31] 
Pp NapAB 
 
-15 +80 +160 Berks et al, 1995 
Breton et al, 1994 
Dd NapA 
 
- - -390 González et al, 2006 [26] 
Se NarB 
 
- - -190 Jepson et al, 2004 
Hi NapB 
 
-170 -25 - Brigé et al, 2002 [81] 
 
Table III. 3 - Redox potential of the metal cofactors comprising the electron pathway connecting NapC to the Mo ion at 
the active site of periplasmic nitrate reductases. (Values between parentheses correspond to redox potential obtained in 
the titration performed on the monomer NapA or NapB. Values are given in mV with respect to the standard hydrogen 
electrode). Se, Synechococcus elongates and Pp, Paracoccus pantotrophus. 
 
When an as-prepared sample of Cn NapAB is incubated with 5 mM sodium dithionite anaerobically, 
the EPR signature of the hemes disappears, consistent with the reduction of the low spin ferric 
porphyrin iron to the ferrous state. Much of the Mo site is not EPR detectable (the intensity of the 
EPR signal at g~2, assigned to a minor Mo(V) species accounts to less than 0.01 spin per molecule). 
In this reduced state, a characteristic signal from [4Fe-4S]+1 (S= 1/2) cluster develops (Figure III. 10 
- A). This paramagnetic species recorded at 25K yields g-values gmax=2.047 (10), gmid=1.951 (8) and 
gmin=1.906-1.900 (10) (line shape parameter Lorentzian/Gaussian= 0.75). At low temperatures, the 
gmin region presents a complex structure that vanishes completely at 50K (inset, Figure III. 10 - B), 
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yielding the g-values gmax = 2.047 (16), gmid = 1.951 (20) and gmin = 1.904 (20) (line shape parameter 
Lorentzian/Gaussian= 0.10). The behavior of the gmin feature with temperature is difficult to interpret 
at this moment. For instance, the Mo-containing aldehyde oxidoreductase from Desulfovibrio gigas 
(MOP) presents a split of the gmax feature for one of the [2Fe-2S] clusters and in the three g-values of 
the Mo (V) species due to the magnetic coupling between the three paramagnetic (S= 1/2) redox 
cofactors present in the enzyme [82, 106, 107]. However, this explanation is difficult to apply in the 
present case since in the dithionite-reduced state, the only paramagnetic species present in the 
enzyme is the [4Fe-4S]+1 cluster.  
 
Another interesting aspect of Cn NapAB [4Fe-4S] cluster is that it can be partially reduced (deduced 
from spin quantification) by incubation with an excess of potassium ascorbate (20 mM). The FeS 
cluster EPR signal is identical to the one obtained with sodium dithionite. An EPR-mediated 
potentiometric titration of this paramagnetic species indicates that the redox potential of the metal 
cluster is -15 mV, which is relatively high for the [4Fe-4S]2+/1+ couple in a periplasmic nitrate 
reductase. A relatively high redox potential for this couple was also observed in the FeS cluster of 
the monomeric NapA from E.coli (+20 mV), but this potential turns negative (-250 mV) when the 
NapAB heterodimer is formed (Table III. 3). Jepson et al. proposed that the reduction potentials of 
the FeS clusters can be affected by the electrostatic surface potential, where a more negative surface 
potential would make the FeS cluster more difficult to reduce, i.e. have lower redox potentials [82].  
 
Figure III. 10 - - Electron paramagnetic resonance (EPR) spectra obtained for the periplasmic Cupriavidus necator 
nitrate reductase heterodimer NapAB. A) Sample as-prepared under aerobic atmosphere measured at 15 K. B) Sample as-
prepared reduced in anaerobic conditions (dioxygen concentration below 1 ppm) with 5 mM sodium dithionite measured 
at 25K. Inset of panel B shows the reduced sample measured at 25K (black) and 50K (gray). Arrows indicate the position 
of the main g-values for the heme and [4Fe-4S]+1 center 
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3.3.9 Electrochemical Characterization 
Non-turnover conditions 
The C.necator NapAB electrochemical behavior was investigated by protein film voltammetry, PFV, 
using graphite electrodes [108]. The heterodimeric periplasmic nitrate reductases from 
P.pantotrophus and R.sphaeroides form very stable films when adsorbed onto graphite electrodes 
[109], and this was experienced for the case of NapAB from C.necator. Cyclic voltammograms (CV) 
at the PGEh electrode in the potential range +160 mV to -600 mV vs SHE and scan rates (v) between 
5 - 50 mVs-1 revealed the presence of one cathodic peak, with an anodic counterpart (Figure III. 11). 
From the difference Ep-Ep/2 = (65-90) mV, it is reasonable to consider that n=1. Although the 
separation between the cathodic, Epc, and the anodic, Epa, peak potentials (/Ep= Epc - Epa) increased 
with v, the average (Epc + Epa)/2 remained almost constant for all scan rates. Therefore, a formal 
reduction potential E0´= (Epc + Epa)/2 = -161 mV vs SHE could be estimated at pH 7.6. In the CVs at 
the UTGEh electrode and in the same experimental conditions, the anodic peak is not easy to 
measure, but Epc compares with the values obtained with the PGEh. From the amount of charge 
consumed in the reduction process and taking into account the geometric areas of the electrodes, 
identical surface coverage areas 6 45 pmol/cm2 were estimated on both electrodes. No voltammetric 
signal was observed with the gold electrode either with the enzyme immobilized on the electrode 
surface (PFV) or using the membrane electrode configuration. 
 
Figure III. 11 – Cyclic voltammograms of C.necator NapAB adsorbed to the pyrolytic graphite electrode in non-
turnover conditions and10 mM Tris-HCl pH7.6 and 0.1M NaCl (scan rates: 5, 10, 15, 20, 30 and 50 mV s-1). 
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Turn-over conditions 
The catalytic activity of the oxidized Cn NapAB was investigated in the potential range 160 mV to -
600 mV vs SHE in the presence of increasing concentrations of potassium nitrate in the electrolyte 
solution (10mM Tris-HCl pH 7.6 and 0.1M NaCl). Several protein/electrode interfaces were tested. 
Most experiments were performed with the enzyme immobilized either on the UTPGEh and using a 
rotation speed of 3000 rpm or on the PGEh electrode with the electrolyte homogenized with a 
magnetic stirrer. In other experiments the enzyme was entrapped in a dialysis membrane and in this 
configuration a gold electrode was also tested. Some experiments were done with the enzyme freely 
diffusing in solution. The promoters polylysine (PLL), 4,4’-dipyridil and the surfactant 
didodecyldimethylammonium bromide (DDAB) were tested. The use of an ionic liquid as a promoter 
(0.4M [C4mim]Cl-, described in Chapter 4), was also investigated. Additionally, enzyme samples 
from different purification batches were tested.  
 
In all situations, the addition of nitrate to the voltammetric cell, in successive proportions of variable 
concentrations (ranging from 10 .M to 10 mM), produced no coherent and/or measurable alteration 
in the cyclic voltammograms. In some experiments with the graphite electrodes, and upon nitrate 
addition, a catalytic wave developed at a potential close to that of the non-turnover signal. However, 
once the solutions were well deaerated, no changes could be detected on the CVs upon nitrate 
addition. It was also observed that upon air or water addition a catalytic wave developed at the same 
potential. Therefore, the appearance of this wave can be attributed to the presence of dissolved 
oxygen in the nitrate solution. Since dissolved oxygen is readily reduced in the potential range 160 to 
-600 vs SHE according to: 
O2 (g)  +  2H+  +  2e-  !  H2O2 
H2O2  +  2H+  +  2e-  !  2H2O 
Increasing amounts of a well-deaerated solution of hydrogen peroxide were added to the 
voltammetric cell with the enzyme immobilized in the UTPGEh. 
 
In the presence of H2O2, a catalytic wave is observed on the cyclic voltammograms and the current 
increases with increasing H2O2 concentration in the range of 50 .M to 500 .M. For the highest 
concentrations the wave loses its peak shape and becomes sigmoidal with a half wave potential value 
E1/2 # -0.155 mV vs SHE, a value close to that of the non-turnover signal and therefore must 
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correspond to the same redox process (Figure III. 12). For each H2O2 concentration the catalytic 
current was measured at the peak potential and the data fitted to the Lineweaver-Burk plot. A 
Michaelis-Menten constant (Km) of 100 µM and a maximum catalytic current imax of 7.5 x1 0-7 Å 
were determined. With the amount of enzyme adsorbed this catalytic current was converted into the 
turnover number, kcat = 5.5 s-1. This catalytic activity was totally unexpected, certainly not related to 
the Mo catalytic site but probably connected to the hemes present in the NapB subunit. As described 
by Paes de Sousa and collaborators [110], altered forms of c-type cytochromes, with either Met-His 
or bis-His-coordination can be induced by interaction with pyrolytic graphite electrodes. This 
interaction promotes the displacement of one of the axial ligands and the altered forms display 
peroxidatic activity. Both E0´ and E1/2 values do not compare with the redox potentials of the heme 
cofactors displayed in Table III.3, which is in agreement with the formation of an altered form of the 
hemes. Moreover, the shape of the catalytic voltammograms and the turnover number estimated for 
the catalytic activity of NapAB towards H2O2 are similar to those reported by Paes de Sousa. The 
protein may be actually facing the electrode through the small di-heme c-type subunit NapB and 
electrons are being directly transferred between the hemes and the electrode. This transfer occurs 
most probably through the solvent exposed heme (Figure III. 3). 
 
 
Figure III. 12 - Cyclic voltammograms of C.necator NapAB adsorbed at a graphite electrode in the presence of 
increasing concentrations of H2O2, in 10 mM Tris-HCl pH 7.6 and 0.1 M NaCl (v = 20 mV s-1, 3000 rpm). 
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The results reported for C.necator NapAB are different from those observed for other nitrate 
reductases investigated by protein film voltammetry using graphite electrodes. In NapAB from 
R.sphaeroides non-turnover-signals are never observed, but the catalytic activity towards nitrate is 
always detected. This activity reaches a maximum at a given potential and then decreases again and 
depending on the experimental conditions (pH and T) the maximum occurs in the range of -100 mV 
to -200 mV vs SHE. In the case of Rs NapAB, the catalytic activity was also proven to be inhibited 
by high substrate concentrations, which constitutes an unprecedented fact for enzymes of the DMSO 
reductase family of Mo proteins. These results suggest that the large catalytic subunit NapA, where 
nitrate is reduced to nitrite, is involved in the voltammetric response [111-113]. 
 
The reason for the different voltammetric behavior between C.necator and R.sphaeroides NapAB 
when adsorbed on graphite electrodes cannot be explained on the basis of simple electrostatic 
electrode/protein interactions. The electrostatic surface potential around the exposed-funnel in the 
case of C.necator is markedly positively charged, as previously mentioned (Figure III. 6), but does 
not seem to interact with the negatively charged graphite surface. In the case of NapAB from 
R.sphaeroides, the electrostatic surface potential is clearly more anionic and neomycin has been 
shown to improve the voltammetric signal stability [113]. Therefore, a favorable electrostatic 
interaction must exist between the electrode surface and the negatively charged region through the 
NH3+ groups of neomycin, so that electrons are exchanged with the catalytic active site. In both 
enzymes, the NapB subunits are very similar and the electrostatic surface potential around the 
exposed heme(s) is positive.  Our voltammetric data suggest that in the case of C.necator NapAB, a 
domain for electron transfer was built up through interactions with the C-O functionalities of the 
graphite surface and the region around the exposed heme. However, this affected the enzyme 
properties and the peroxidatic activity displayed by C.necator NapAB does not, or may not, have 
biological relevance.  
 
C.necator NapAB is located on the periplasmic compartment of the cell, thus, exposition to different 
concentrations of nitrate substrate during natural biochemical processes (or in the culture medium) 
may explain some of its indifference towards the presence of nitrate in the electrolytic cell. The 
protein may have developed a protection mechanism, leading to a required protein pre-activation for 
nitrate consumption. New experiments are necessary to answer this question. 
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4 CHAPTER 4  
Protein Crystallization using Ionic Liquids 
 
 
 
 
 
 
 
 
 
The work described in this chapter was the subject of the following publication: 
 
C. Coelho, J. Trincão, and M. J. Romão (2010) “The use of ionic liquids as crystallization additives 
allowed to overcome nanodrop scaling up problems: A success case for producing diffraction-quality 
crystals of a nitrate reductase” Journal of Crystal Growth, 312, 714-719. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 97 
 
4.1 INTRODUCTION 
4.1.1 Limitations in Protein Crystallization 
Protein crystallization is a key step in determining a macromolecule three-dimensional structure. 
Many proteins are difficult to crystallize. The propensity to form, an orderly packed array of 
molecules or not in the form of a crystal can be related with some intrinsic properties. The protein 
molecular size might be important, since larger proteins are more likely to have segments of residues 
with limited mobility, which hinder crystallization. Another important feature is protein solubility, 
since the protein must be able to decrease its solubility in the precipitant to start nucleation. Protein 
crystallization can also be determined by chemical interaction between macromolecules, usually the 
larger the differences between various possible contacts, the easier it is to produce a good crystal. 
There are also external protein factors responsible for limitations in obtaining crystals. The most 
common is generally the limited amount of biomaterial available. Some proteins are very hard to 
produce and difficult to purify and the final yield can be very low, limiting the number of screens 
that can be setup by the crystallographer to achieve crystallization conditions. 
 
Recent advances in robotics and computer control, driven by some structural genomics initiatives 
around the world, have been developed in order to overcome some of these difficulties. The use of 
dispensing nanodrop crystallization robots is one of them and is becoming very popular. In the 
particular case of the nitrate reductase from C.necator, due to the limited amount of protein available 
initially, the High Throughput Crystallization Facility at EMBL Grenoble, which offers automated 
nanovolume crystallization screening on a service basis, was requested for the crystallization setups 
[86]. This facility has the particularity of performing the crystallization experiments, which can be 
followed up after by users, through automated imaging systems (through a real-time dedicated web 
interface). A total of 96 different crystallization conditions were tested, with the 16 .l of pure 
C.necator nitrate reductase available at 10 mg/ml. For common manual crystallization this reduced 
amount of protein would only be sufficient to setup one crystallization plate of 24 different 
conditions. The protein sent to the robot, successfully crystallized in several different conditions and 
two of them in particular gave crystals that were suitable for diffraction data collection. The native 
structure of NapAB could be solved at 1.5Å resolution, using data from one of these robot 
microcrystals (Chapter 3). This case illustrates the efficient and reliable possibilities of using a 
crystallization robot. 
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Very recently an Oryx8 protein crystallization robot (Douglas Instruments) was acquired by our 
research group (Crystallography group at Faculdade de Ciências e Tecnologia from Universidade 
Nova de Lisboa) and all the nanocrystallization setups can now be performed in-house. 
 
4.1.2 Limitations to Scale up Robot Conditions 
The C.necator NapAB crystal structure raised new questions that lead to the need of obtaining 
additional crystallographic data for other enzyme forms. Corroboration of the new mechanistic 
evidences related with the assignment of sulfur as the 6th molybdenum ligand and the pursuit of 
additional mechanistic studies were the main reasons for pursuing crystallographic studies on 
C.necator NapAB [32, 33]. New experiments should include crystallographic studies for different 
forms of the enzyme, namely reduced forms, as well as of complexes with substrates analogues and 
inhibitors. As an initial approach to obtain new data, the best robot crystallization conditions were 
reproduced using larger drop volumes, a procedure commonly referred as scale up. Despite being an 
empirical procedure, in practical terms it may become difficult to accomplish and no NapAB crystals 
could be obtained by simply using this approach. The change in equilibration kinetics, due to the 
larger surface area to volume ratio of the nanodrops is possibly one of the major causes for this 
specific problem, together with different evaporation rates. Other external causes may be related with 
variations among protein batches and aging samples, commercial versus homemade solutions or a 
mixed combination of several factors. 
 
Crystallographers are always searching for new and efficient crystallization protocols, which enable 
them to obtain better diffracting crystals. When there are no limitations, particularly concerning the 
amount of protein available, several different conditions are tested within the initial crystallization 
condition. This includes, besides screening the precipitant concentration, pH and buffers, the 
screening of different crystallization temperatures, and the use of different additives in the mixture. 
Some seeding techniques are also regularly performed, with the objective of introducing external 
crystallization nuclei in the protein solution to induce nucleation. For the scale up of nitrate reductase 
crystals, seeding experiments were also tested as well as several additives, particularly some with 
biological significance for the protein (substrate and inhibitors), but with no positive results. Only 
long thin needles were obtained, not suitable for diffraction experiments.  
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In the pursuit for new crystallization methodologies, some recently described compounds named 
ionic liquids (IL) were tested as crystallization additives. The results obtained were very promising, 
as explained below. 
 
4.1.3 Ionic Liquids and Proteins 
Room temperature ionic liquids (IL) are salts that do not crystallize at room temperature. They are 
composed of an organic cation (for example, 1-butyl-3-methylimidazolium or [C4mim]) and any of a 
variety of organic/inorganic counter-anions (Cl-, PF6- or BF4-, for example) (Figure IV. 1). Ionic 
liquids have been investigated as environmentally friendly replacements for organic solvents: due to 
their negligible vapor pressure they can be efficiently reused. They also possess high thermal and 
chemical stability and have been used in several areas of research such as green chemistry, 
enzymatic catalysis and electrochemistry, making the most of their excellent stability and unusual 
solvent properties. Depending on their structure, they can be immiscible or not with water. 
Biocatalytic reactions in ionic liquids have shown higher selectivity, faster rates and enhanced 
enzyme stability. Ionic liquids can be considered as “personalized solvents” because it’s easy to 
change their structure and thus their solvent properties. IL are more viscous than typical organic 
solvents, probably due to the strong intermolecular forces between solvent molecules. The charge to 
charge interactions is inherent in ionic liquids, but reducing van der Waals interactions by reducing 
the surface area of the molecule can slightly lower the viscosity. Ionic liquids with shorter alkyl 
chains are less viscous than those with longer ones. There are more than 1000 different ionic liquids 
described in the literature, from which 300 are already commercially available. They are much more 
expensive than organic solvents and the key to make their use more profitable will be to develop 
efficient recovery, isolation and reuse [114-116]. 
 
The interactions between ionic liquids and proteins have been investigated in recent years. Enzymes 
suspended in ionic liquids remain stable and catalytic active, even though they are not stable or 
active in conventional polar organic solvents. Ionic liquids have been demonstrated also to improve 
protein refolding following denaturation. This is particular relevant nowadays, due to the common 
expression of recombinant proteins in prokaryotic systems, which in the majority of the cases lack 
the proper refolding machinery. Due to their ionic nature, they may interact with charged groups of 
enzymes, either in the active site or in the surface, giving rise to protein structural changes. Unlike 
conventional organic solvents, ionic liquids possess no vapor pressure, and are able to dissolve many 
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compounds. These non-aqueous but polar solvents may also constitute a new and efficient media for 
enzyme catalysis. The possibility to tune ionic liquids properties, such as solubility, polarity or 
hydrophilicity, by selecting the appropriate combination anion/cation, makes them remarkably 
versatile for many applications [117-119]. 
 
 
Figure IV. 1 – Some common ionic liquids used in protein crystallography. 
 
4.1.4 Protein Crystallization and Ionic Liquids 
Despite the large number of studies relating ionic liquids and protein stabilization or renaturation, 
there were only a few reports on the use of IL in protein crystallization, when the scale up trials for 
the nitrate reductase crystals were started. The first study dates from 1999 and reports the use of 
ethyl ammonium nitrate in the crystallization of lysozyme [120]. In a subsequent study, Pusey and 
collaborators described crystal improvement of four different proteins (canavalin, %-lactoglobulin B, 
xylanase and glucose isomerase, respectively), with the use of three different IL [121]. However, all 
these studies were performed in model proteins, which posed no major crystallization problems. 
Furthermore, only crystal morphology was assessed, and no details from diffraction quality of the 
improved crystals were given. Recently, a third publication was available in which the authors 
performed similar experiments as Pusey and co-workers, for other model proteins (lysozyme, 
 101 
 
catalase, myoglobin, trypsin, xylanase and glucose isomerase) and a monoclonal antibody Fab in 
complex with a peptide [122]. In this case, improvement of crystal size was only observed for 
lysozyme and trypsin. For every study the authors reported that all proteins retained their catalytic 
activity after incubation with ionic liquids, and that crystals were obtained at a number of conditions 
where they were absent from IL-free control experiments. This approach seemed very promising, 
and although limited by the reduced amount of protein available, two water-soluble ionic liquids 
were tested in an attempt to scale up the robot crystallization conditions for the C.necator nitrate 
reductase. 
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4.2 C.NECATOR NAPAB: A CASE STUDY 
4.2.1 Protein Expression and Purification 
C.necator periplasmic nitrate reductase was expressed and purified as mentioned in chapter 3 of this 
Thesis (sections 3.2.1 and 3.2.2).  The protein used to scale up the initial robot conditions was 
obtained from the 10L BioStat B-Plus reactor batch. Final protein concentration was 10 mg/ml in 10 
mM Tris-HCl pH 7.6 buffer. 
 
4.2.2 Crystallization 
Crystallization drops were setup at 20ºC, using the sitting-drop vapor diffusion method, as in the 
crystallization robot. Initial attempts were made using the same conditions for the best crystals 
obtained by the robot (condition 42: 0.1M Bis-Tris pH 5.5, 25% w/v PEG 3350 and condition 90: 
0.2M sodium formate, 20% w/v PEG 3350), but increasing ten times the drop volume (from 0.2.l in 
the robot, to 2.l in manual setup). Crystallization stock solutions number 42 and 90 from Index 
Crystallization Screen were purchased from Hampton research. As no crystals were obtained, a PEG 
3350 screen concentration was performed, which lead to the formation of micro needles and sea 
urchins, but no measurable crystals. Seeding experiments were also tested as well as additives (such 
as potassium nitrate, sodium azide, MPD, sodium malonate and sodium dithionite). Due to the 
continuous lack of results, we pursued a new approach, using water soluble ionic liquids (IL) that 
were tested as crystallization additives. Due to the small amount of protein available only two 
different IL were selected for the experiments: [C4mim] Cl- (1-butyl-3-methylimidazolium chloride) 
and [C4mim] [MDEGSO4] (1-butyl-3-methylimidazolium 2(2-methoxyethoxy) ethyl sulphate), both 
available from Fluka. The main objective of this choice was to maintain the cation ([C4mim]] while 
changing the anion. The protein was incubated either with 0.2M and 0.4M of [C4mim] Cl- and 
[C4mim] [MDEGSO4], for several minutes before setting up the crystallization drops. All values for 
ionic liquid concentration are in respect to final concentration in protein solution. Crystal for the 
nitrate reductase protein with overall dimensions of 0.3 x 0.1 x 0.1 mm3 were obtained within two 
days, using 0.2M sodium formate, 15% PEG 3350 and 0.4M [C4mim] Cl-. 
 
To ensure that manual crystallization conditions were as similar as possible to the robot, all scale up 
experiments (with or without ionic liquids) were performed using the same crystallization solutions, 
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at the same temperature (20ºC) and with the same protein batch purification. A sample from this 
batch (10L BioStat B-Plus reactor batch) was also sent to the crystallization robot facility in EMBL 
to prove that the differences from the two protein batches (robot-batch and 10L batch) were not the 
cause for reproducibility problems. 
 
4.2.3 Data Collection and Analysis 
The best crystals were harvested in a solution containing a higher precipitant concentration (25% 
PEG 3350, and 0.2M sodium formate) and allowed to stabilize for several minutes before cryo-
cooling with paratone oil as cryoprotectant. Crystals were flash cooled and stored in liquid nitrogen, 
and several datasets were collected at the ESRF (beamlines ID 14-1 and 14-2), using ADSC 
Quantum-4R CCD detectors. In general crystals diffracted in a range of 2 to 3.5Å, with some few 
crystals diffracting as well as the initial ones obtained at the robot (Table IV. 1). Subsequent soaking 
experiments, using 20 mM sodium dithionite were performed in some crystals obtained with the help 
of the ionic liquid, as previously mentioned in Chapter 3 (Table III. 1, dataset name DIT-IL). 
 
Dataset name DIT-IL (2007) Nap_IL (2008) Nap_IL (2009) 
Beamline (ESRF) ID14-2 ID 14-1 ID14-2 
Space Group C2 C2 C2 
 
Cell constants 
a = 119.4 Å, b = 71.4 Å, 
c = 128.4 Å and " = 
121.0º 
a = 135.5 Å, b = 71.8 
Å, c = 114.9 Å and " 
= 110.5º 
a = 121.7 Å, b = 71.2 Å, 
c = 121.7Å and " = 
115.0º 
Resolution (Å) 1.7 2.7 2.0 
Matthew’s coefficient 
(Å3/Da) 
2.32 2.45 2.23 
Solvent content (%) 46.90 49.75 44.95 
 
 
Crystallization 
conditions 
 
0.2M sodium formate 
15% PEG 3350 
0.4M [C4mim] Cl- 
20mM sodium dithionite 
 
 
0.2M sodium formate 
15% PEG 3350 
0.4M [C4mim] Cl- 
 
 
0.2M sodium formate 
15% PEG 3350 
0.4M [C4mim] Cl- 
20mM sodium dithionite 
 
Table IV. 1 – Crystal parameters and X-ray diffraction data statistics for the best diffracting crystals obtained using ionic 
liquids. 
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4.3 RESULTS AND DISCUSSION 
All attempts to reproduce in house the crystals obtained at the High Throughput crystallization robot, 
but using larger volume drops had failed. The only crystallization results obtained were precipitate, 
small urchins and thin needles (Figure IV. 2). To overcome this problem, two different ionic liquids 
([C4mim] Cl- and [C4mim] [MDEGSO4]) were tested as crystallization additives. In both cases 
decreased nucleation was observed, and with 0.4M of [C4mim] [MDEGSO4], the needles were larger 
although still very thin for diffraction experiments (Figure IV. 3). With 0.4M [C4mim] Cl- as 
crystallization additive in the protein solution, good results were achieved and large single crystals 
were obtained in a reproducible manner (Figure IV. 4). When using a lesser amount of this IL in the 
protein solution (0.2M), no good crystals were obtained (Figure IV. 3). The changes in the counter 
ion, as well as the ionic liquid concentration, were crucial for successful optimization of 
crystallization. 
 
 
Figure IV. 2 - Microdrop crystallization in the absence of ionic liquids: (a) condition 0.2M sodium formate and 15% 
PEG 3350, protein concentration 5 mg/ml; (b) sea urchins obtained using 0.2M sodium formate and 12.5% PEG 3350; 
(c) streak seeding from drop (b); (d) long but fine needles obtained in the same condition (a) but with protein 
concentration 10 mg/ml. 
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Figure IV. 3 - Microdrop crystallization in the presence of (a) 0.4M [C4mim] [MDEGSO4] (b) 0.2M [C4mim] 
[MDEGSO4] and (c) 0.2M [C4mim] Cl-. Crystallization conditions are 0.2M sodium formate, 15% PEG 3350. 
 
 
Figure IV. 4 - Microdrop crystals obtained in the presence of 0.4M [C4mim] Cl- revealing crystallization reproducibility. 
Crystallization conditions are 0.2M sodium formate and 15% PEG 3350. Approximate crystal dimensions 0.3 x 0.1 x 0.1 
mm3. 
 
The maximum resolution for each dataset was very dependent not only in intrinsic crystal quality but 
also on crystal handling and cryo-cooling. C.necator NapAB crystals were very sensitive, and typical 
diffraction observed ranged between 2-3Å, with only about 20% of the crystals diffracting 
isotropically to the same resolution as the ones obtained from the robot. Though the majority of the 
crystals seemed unique, diffraction data showed two lattices after data collection for some of the 
crystals, probably a consequence from crystal manipulation and cooling. To avoid overlaps during 
data collection, the X-ray detector was moved further away from the crystal to increase the distance 
and the ability to process data all the way to the detector corner (Figure IV. 5). 
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Figure IV. 5 - C.necator NapAB protein diffraction pattern of a crystal obtained in-house, using 0.4M [C4mim] Cl-. 
Resolution at edge is 2Å and dataset name Nap_IL (2009) from Table IV.1 
 
 
 
All crystals from C.necator nitrate reductase grown in the presence of the ionic liquid belong to the 
same space group C2 as the native crystal, obtained in the crystallization robot. Despite belonging to 
the same space group, differences can be observed in cell constants dimensions. Particularly for the 
case described in the previous Chapter 3 (dataset name DIT-IL), where differences in unit cell 
parameters account for a decrease of 16% and 13% in the a and b axes respectively, while the c axis 
showed an increase of 33% (Table IV. 1). This leads to a small decrease in unit cell volume (9%), 
but large differences in crystal packing (Figure IV. 6). The differences in cell dimensions are 
accompanied by differences in the relative positioning of the individual molecules in the crystal 
lattice, induced by the presence of the ionic liquid in the protein. These differences clearly 
demonstrate the interaction between the ionic liquids and the protein molecules, which in this 
particular case were probably necessary to hold the conformational changes that occurred in the 
soaking experiments, with the reducing agent sodium dithionite. 
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Figure IV. 6 - Changes in the crystal packing. Upper Left: crystal packing for the native protein, with unit cell constants 
a = 142.2Å, b = 82.4Å, c = 96.8Å and % = 100.7º (46.9% solvent); Upper Right: packing of crystals obtained with IL, 
unit cell constants a = 119.4Å, b = 71.4Å, c = 128.4Å and % = 121.0º (51.5% solvent content); Center: comparison of the 
two unit cells constants, projected along the b axis. With IL, a and b axes decrease respectively 16% and 13%, while c 
axis increased 33%. 
 
After careful inspection of the electron density map, no IL molecules could be clearly identified. 
Also in the recent work of Judge and co-workers [122], where crystals of two model proteins and a 
Fab complex were obtained in the presence of ionic liquids, no IL molecules could be assigned in the 
crystal structures. This might be due to some disorder in the crystal, to unspecific binding or even no 
binding of ionic liquid molecules to the protein. Although they could not be identified in the crystal 
structure, IL molecules must affect specific crystallization contacts within the crystal. This could 
explain the large differences observed in the cell constants for crystals grown in the presence of IL, 
resulting from changes in the relative packing of the molecules. The way ionic liquids affect protein 
crystallization cannot be explained by a single mechanism, but rather a combination of several 
different factors. Changes in growth kinetics and in solution properties might be important, but also 
variations in the vapor equilibration rate. The presence of ionic liquid can conduce a slower 
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evaporation rate, and consequently to different molecule packing. Ionic liquids can also be 
responsible for changes in protein solubility as previously mentioned. 
 
The difference encountered when changing from chloride (Cl-) to a larger anion such as 2(2-
methoxyethoxy) ethyl sulphate (MDEGSO4), might be explained by recent studies elucidating the 
differences among the structures of the [C4mim] with different anions. Ionic liquids have localized 
structures around each ion, constituted by pairs of ions and not dissociated ions as previously thought 
[123, 124]. Comparing the results obtained for the difficult case of the nitrate reductase, as well as 
those from model proteins using the cation [C4mim], it is easily observable that it has the largest 
success rate. 
 
It is important to note that due to the rather limited amount of protein (before the 300L industrial 
bacterial growth), and the successful results obtained with 0.4M [C4mim] Cl-, a more extensive 
screen was not performed. It is also important to mention that with the sample from the 10L batch 
that was sent again to the robot facility in EMBL, it was possible to reproduce the initial 
microcrystals obtained. This proves that the difference from the two protein batches was not the 
cause of reproducibility problems during scale up attempts. 
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4.4 CONCLUSIONS 
The use of dispensing robots is becoming a very common and popular practice in the protein 
crystallography community. These robots possess several impressive features, such as allowing for 
very fast screening of a wide range of conditions, in controlled environments, and using minimal 
amounts of protein. Although very powerful in the initial crystallization process, they are generally 
not used in the following crystallization optimization steps. In addition, the increasing need to scale 
up from nanodrops to regular drops is becoming quite problematic. Despite the several advances in 
protein crystallography it is still not possible to define general crystallization protocols, since each 
individual protein has its intrinsic properties and requirements for successful crystallization. The 
crystallization of C.necator NapAB constitutes the first reported case on the use of ionic liquids to 
solve a real difficult case scenario. The use of ionic liquid as a crystallization additive allowed 
overcoming the volume scale up problem. The reproducibility of good quality crystals will allow 
pursuing the mechanistic studies on the periplasmic nitrate reductase. The results here reported may 
define a strategy that can be applied to many other cases. These organic salts can also be used to 
optimize crystal properties, such as size and morphology, to improve data diffraction or enhance 
protein stability. Depending on the amount of pure protein available, when screening crystallization 
conditions using ionic liquids, one should try different cation/anion combinations, such as using 
larger versus smaller ones, while maintaining the same cation. The final concentration of IL in the 
protein solution should be between 0.2M and 0.6M, the most studied range of concentrations for 
protein-IL interactions. 
 
One clear remarkable sign of the importance and usefulness of ionic liquids in protein crystallization 
is the recent market launch of a screen of additives for protein crystallization, composed entirely of 
ionic liquids (Ionic Liquid Screen from Hampton Research). 
. 
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5.1 GENERAL CONCLUSIONS 
Mouse aldehyde oxidase homologue1 (mAOH1) and C.necator periplasmic nitrate reductase (Cn 
NapAB) are two molybdopterin dependent enzymes. Due to the characteristics and specificities of 
their catalytic active sites the two proteins belong to different Mo containing enzymes families. 
mAOH1 is a protein homologue to aldehyde oxidase and belongs to the xanthine oxidase family, 
while Cn NapAB belongs to the DMSO reductase family. The three dimensional structure for the 
two proteins was determined by X-ray protein crystallography and studies regarding function, 
chemical behavior and structure specificities were performed for the nitrate reductase.  
 
The recombinant mAOH1 enzyme was used to optimize the crystallization conditions for the native 
enzyme from mouse liver. After extensive trials, a usable dataset was collected at 2.9Å resolution for 
the native protein crystals. The structure was solved by molecular replacement using the homologous 
protein xanthine oxidase (XO). This constitutes the first structure ever obtained for an aldehyde 
oxidase. It is known that human AO (AOX1) is involved in drug metabolizing processes, possibly 
through xenobiotic detoxification, and the recognition of its importance has been increasing in recent 
years. Several pharmaceutical companies have been studying the protein interaction with a large 
number of different drugs.  The range of substrates is much broader in aldehyde oxidase than in 
xanthine oxidase, despite their remarkable overall similarity. With the mAOH1 crystal structure, we 
were able to identify crucial residues in the protein active site responsible for the binding of different 
substrates, particularly large and bulky N-heterocycles. Also, the differences in the active site funnel, 
which leads to the molybdopterin cofactor, could be addressed. The mAOH1 funnel is much wider 
and able to accommodate some substrates that are unable to be metabolized by XOR. An inter-
conversion mechanism (XDH!XO) exists in mammalian xanthine oxidoreductases, which was 
never described for other XO family members, including mAOH1. Some important protein residues 
involved in this inter-conversion mechanism were assigned in mAOH1, and their comparison with 
bovine XOR helped to explain the lackof such mechanism in aldehyde oxidases. 
 
Several crystal structures from periplasmic nitrate reductases proteins have been solved in the last 
twelve years, both for monomeric and heterodimeric proteins. These structures were solved at a 
resolution that couldn’t unequivocally assign all the Mo ligands, and the 6th molybdenum position 
was believed to be occupied by an O/OH group. The heterodimeric nitrate reductase from C.necator 
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is homologous to the previous protein structures reported, but its structure could be solved at 1.5Å 
resolution, constituting the highest resolution structure obtained for a nitrate reductase so far. With 
high resolution, clear electron density was observed for an atom heavier than oxygen at the Mo 6th 
position. The B-factor analysis provided corroboration and the ligand could be unambiguously 
assigned as a sulfur atom. The same procedure was used for the monomeric nitrate reductase from 
D.desulfuricans in recent crystallographic studies, with the same result. It is likely that this 
constitutes a common feature for all periplasmic nitrate reductases. In addition, the partially reduced 
form of the enzyme could be obtained at 1.7Å, and has particular importance in explaining the 
protein reaction mechanism. This NapAB partially reduced form was obtained using ionic liquids as 
described in detail in the case study reported. These novel compounds have proven to be useful as 
crystallization additives. They were also decisive to achieve the partially reduced form of the enzyme 
in this specific case. The C.necator NapAB spectroscopic and electrochemical studies also revealed 
some unexpected features of the protein, particularly the different hemes potentials observed when 
comparing with the homologous heterodimeric NapAB from R.sphaeroides. Moreover, the lack of a 
catalytic voltammetric response towards the natural substrate nitrate was unexpected, since it was 
already described and reported for the homologous Rs NapAB. 
 
5.2 FUTURE PERSPECTIVES 
When solving a new protein three-dimensional structure, some answers can be given to the universe 
of pre-existing questions regarding that particular structure. Nevertheless, many more questions are 
raised afterwards. This becomes very clear, when a crystallographer is able to solve its first protein 
crystal structure. 
 
There are still many open and important questions directly related to what was explored in this 
Thesis, particularly regarding the mAOH1 protein. To answer some of these burning questions, one 
of the first steps is to try to improve the protein crystals, in order to extend diffraction. The main goal 
is to perform crystal soaking experiments, particularly with the important compounds that have been 
described to be metabolized by aldehyde oxidases, in particular those of pharmacological relevance. 
The ability to analyze where these compounds bind in the protein active site would be of great 
interest. With the now available coordinates, some substrate docking studies and molecular 
simulations can also be performed simultaneously, and the results compared afterwards. With the 
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increasing importance of aldehyde oxidase for the pharmaceutical companies, drug design studies 
should not be forgotten as an aim to our studies. 
 
Biochemical studies have shown different specificities among the different aldehyde oxidase 
isoforms, particularly between mAOH1 and mAOH2. It would also be of great value to solve the 
crystal structure for the mAOH2 isoform and perform structural comparisons. The amount of protein 
is very limited, but with the recently available and improved expression system it should be feasible. 
Also, the crystallization robot can be helpful in these particular cases. Ionic liquids should again be 
helpful in this task, not only as crystallization additives, but also as protein stabilizing agents, as has 
been described for several enzymes. 
 
Also for the nitrate reductase protein, there are still interesting experiments waiting to be done and 
several aspects needing to be solved. The complete reduced form of the enzyme would be very good 
to achieve and further experiments using the anaerobic chamber can be of special help in this case. 
The ionic liquids should also be useful. With the now available large Cn NapAB protein quantity, a 
broader ionic liquids screen can be performed, in the pursuit to better understand their particular 
properties and protein interactions in protein crystallization. Assigning ionic liquids in the electron 
density maps would also be very interesting and such experiments must be performed.  
 
Nevertheless, the main and more important accomplishment to be done in the near future is to be 
able to solve the crystal structure of the human Aldehyde oxidase, from which diffracting crystals 
were very recently obtained. This constitutes a very challenging project, and hopefully all the 
necessary conditions are met, so that this project can be pursued. 
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Table 1 - Mineral medium composition for C.necator growth under aerobic conditions 
Mediuma Final concentration Amounts 
10L Growth 
Amounts 
300L Growth 
MgSO4.7H2O 
 
0.02% 2 g 60 g 
CaCl2.2H2O 
 
0.001% 0.1 g 3 g 
 
NH4Cl 
 
0.2% 20 g 600 g 
FeCl3 
 
0.0005% 0.05 g 1.5 g 
Fructose 
 
0.4% 40 g 1200 g 
SL6 solutionb 
 
0.1% 50 ml 300 ml 
H16 buffer 
(Na2HPO4/ KH2PO4) 
 
-  
90 / 15 g 
 
2700 / 450 g 
Tetracycline 
 
10 mg/ml 0.1 g 3 g 
Antifoam 
(Simethicone) 
- 1 g 30 g 
a All solutions were autoclaved 20 min at 120ºC, except the FeCl3, the Fructose and Tetracycline solutions, that were 
sterilized using ultrafitration with 0.2 µm pore diameter. 
b SL6 solution corresponds to an oligoelement solution composed by: ZnSO4.7H2O; MnCl2.4H2O; H3BO3; CoCL2.6H2O; 
CuCl2.6H2O; NiCl2.6H2O; Na2MoO4. 
 
 
Figure 1 - Comparison between C.necator 300L and 10L growths 
 
 
O!
H!
E!
G!
?!
D!
B!
O! D! HO! HD! EO! ED! GO! GD! ?O! ?D! DO!
8
9'
.2
2'
:;
'
<;='>?@'
HO+!5*#")(+!
GOO+!49%#!
 130 
 
Table 2 - Index Formulation from Hampton Research (2008) 
H>!!!!O>H!&!*cdecf!gfch!i$!G>D:!E>O!&!,jjklcmj!nmopgdq!!!
E>!!!!O>H!&!2khcmj!gfqdgdq!decrshegdq!i$!?>D:!E>O!&!,jjklcmj!nmopgdq!
G>!!!!O>H!&!942"#-42!i$!D>D:!E>O!&!,jjklcmj!nmopgdq!!!!
?>!!!!O>H!&!942"#-42!i$!B>D:!E>O!&!,jjklcmj!nmopgdq!!!!!
D>!!!!O>H!&!$%3%2!i$!F>D:!E>O!&!,jjklcmj!nmopgdq!!!!!
B>!!!!O>H!&!#ecn!i$!L>D:!E>O!&!,jjklcmj!nmopgdq!!!!!
F>!!!!O>H!&!*cdecf!gfch!i$!G>D:!G>O!&!2khcmj!frokechq!!!!
L>!!!!O>H!&!2khcmj!gfqdgdq!decrshegdq!i$!?>D:!G>O!&!2khcmj!frokechq!!!!
M>!!!!O>H!&!942"#-42!i$!D>D:!G>O!&!2khcmj!frokechq!!!!
HO>!!!O>H!&!942"#-42!i$!B>D:!G>O!&!2khcmj!frokechq!!!
HH>!!!O>H!&!$%3%2!i$!F>D:!G>O!&!2khcmj!frokechq!!!!
HE>!!!O>H!&!#ecn!i$!L>D:!G>O!&!2khcmj!frokechq!!!!
HG>!!!O>H!&!942"#-42!i$!D>D:!O>G!&!&gtlqncmj!pkejgdq!hcrshegdq!!!!
H?>!!!O>H!&!942"#-42!i$!B>D:!O>D!&!&gtlqncmj!pkejgdq!hcrshegdq!!!!
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